The	O
human	B-DNA
prointerleukin	I-DNA
1	I-DNA
beta	I-DNA
gene	I-DNA
requires	O
DNA	O
sequences	O
both	O
proximal	O
and	O
distal	O
to	O
the	O
transcription	B-DNA
start	I-DNA
site	I-DNA
for	O
tissue-specific	O
induction	O
.	O

In	O
these	O
studies	O
,	O
we	O
have	O
identified	O
DNA	B-DNA
sequences	I-DNA
and	O
specific	O
protein	O
interactions	O
necessary	O
for	O
transcriptional	O
regulation	O
of	O
the	O
human	B-DNA
prointerleukin	I-DNA
1	I-DNA
beta	I-DNA
(	I-DNA
proIL-1	I-DNA
beta	I-DNA
)	I-DNA
gene	I-DNA
.	O

A	O
cell-type-independent	B-DNA
lipopolysaccharide	I-DNA
(	I-DNA
LPS	I-DNA
)	I-DNA
-responsive	I-DNA
enhancer	I-DNA
element	I-DNA
located	O
between	O
-3757	B-DNA
and	I-DNA
-2729	I-DNA
bp	I-DNA
upstream	I-DNA
from	O
the	O
transcription	B-DNA
start	I-DNA
site	I-DNA
(	O
cap	B-DNA
site	I-DNA
)	O
consisted	O
of	O
at	O
least	O
six	O
discrete	O
subregions	O
which	O
were	O
essential	O
to	O
the	O
maximal	O
induction	O
by	O
LPS	O
in	O
transfected	B-cell_line
monocytes	I-cell_line
.	O

The	O
enhancer	O
also	O
appeared	O
to	O
mediate	O
phorbol	O
myristate	O
acetate	O
induction	O
in	O
monocytes	B-cell_type
and	O
IL-1	B-protein
responsiveness	O
in	O
fibroblasts	B-cell_type
.	O

Deletion	O
and	O
base	O
substitution	O
mutations	O
along	O
with	O
DNA	O
binding	O
studies	O
demonstrated	O
that	O
the	O
enhancer	O
contained	O
a	O
minimum	O
of	O
three	O
functional	O
protein	B-DNA
binding	I-DNA
sequences	I-DNA
,	O
two	O
of	O
which	O
appeared	O
to	O
be	O
important	O
for	O
gene	O
induction	O
.	O

One	O
of	O
the	O
essential	O
proteins	O
which	O
bound	O
to	O
the	O
enhancer	O
was	O
similar	O
or	O
identical	O
to	O
members	O
of	O
the	O
C/EBP	B-protein
family	I-protein
of	O
transcription	B-protein
factors	I-protein
required	O
for	O
both	O
IL-1	B-protein
-and	O
LPS-specific	O
induction	O
of	O
the	O
IL-6	B-DNA
gene	I-DNA
(	O
i.e.	O
,	O
the	O
NF-IL6	B-DNA
proteins	I-DNA
)	O
.	O

When	O
ligated	O
to	O
the	O
proIL-1	B-DNA
beta	I-DNA
cap	I-DNA
site	I-DNA
-proximal	B-DNA
region	I-DNA
(	O
located	O
between	O
-131	O
to	O
+12	O
)	O
,	O
both	O
the	O
proIL-1	B-DNA
beta	I-DNA
and	I-DNA
the	I-DNA
simian	I-DNA
virus	I-DNA
40	I-DNA
enhancer	I-DNA
elements	I-DNA
functioned	O
more	O
efficiently	O
in	O
monocytes	B-cell_type
than	O
in	O
HeLa	B-cell_type
cells	I-cell_type
,	O
which	O
are	O
not	O
normally	O
competent	O
for	O
IL-1	B-protein
beta	I-protein
expression	O
.	O

When	O
ligated	O
to	O
the	O
murine	B-DNA
c-fos	I-DNA
promoter	I-DNA
,	O
however	O
,	O
the	O
proIL-1	B-DNA
beta	I-DNA
enhancer	I-DNA
was	O
inducible	O
in	O
phorbol	B-cell_line
myristate	I-cell_line
acetate-stimulated	I-cell_line
HeLa	I-cell_line
cells	I-cell_line
,	O
suggesting	O
the	O
existence	O
of	O
a	O
proIL-1	B-protein
beta	I-protein
promoter-proximal	O
requirement	O
for	O
tissue	O
specificity	O
.	O

MoLECULAR	NULL
aND	NULL
CELLULAR	NULL
Brorogy	NULL
,	NULL
Mar	NULL
.	NULL

1993	NULL
,	NULL
p.	NULL
1332-1344	NULL
0270-7306/93/031332-13	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1993	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

13	NULL
,	NULL
No	NULL
.	NULL

3	NULL
The	NULL
Human	NULL
Prointerleukin	NULL
1B	NULL
Gene	NULL
Requires	NULL
DNA	NULL
Sequences	NULL
Both	NULL
Proximal	NULL
and	NULL
Distal	NULL
to	NULL
the	NULL
Transcription	NULL
Start	NULL
Site	NULL
for	NULL
Tissue-Specific	NULL
Induction	NULL
FUMIHIKO	NULL
SHIRAKAWA	NULL
,	NULL
'+	NULL
KAZUYOSHI	NULL
SAITO	NULL
,	NULL
``	NULL
CHRISTOPHER	NULL
A.	NULL
BONAGURA	NULL
,	NULL
'	NULL
DEBORAH	NULL
L.	NULL
GALSON	NULL
,	NULL
*	NULL
MATTHEW	NULL
J.	NULL
FENTON	NULL
,	NULL
``	NULL
ANDREW	NULL
C.	NULL
WEBB	NULL
,	NULL
``	NULL
anp	NULL
PHILIP	NULL
E.	NULL
AURON®'**	NULL
The	NULL
Center	NULL
for	NULL
Blood	NULL
Research	NULL
'	NULL
and	NULL
Division	NULL
of	NULL
Hematology-Oncology	NULL
,	NULL
Brigham	NULL
and	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
``	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
;	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Boston	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
and	NULL
Evans	NULL
Department	NULL
of	NULL
Clinical	NULL
Research	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02118	NULL
;	NULL
Department	NULL
of	NULL
Biological	NULL
Sciences	NULL
,	NULL
Wellesley	NULL
College	NULL
,	NULL
Wellesley	NULL
,	NULL
Massachusetts	NULL
02181	NULL
%	NULL
;	NULL
and	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Massachusetts	NULL
General	NULL
Hospital	NULL
,	NULL
Charlestown	NULL
,	NULL
Massachusetts	NULL
02129	NULL
and	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115°	NULL
Received	NULL
1	NULL
September	NULL
1992/Returned	NULL
for	NULL
modification	NULL
25	NULL
September	NULL
1992/Accepted	NULL
9	NULL
December	NULL
1992	NULL
In	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
DNA	NULL
sequences	NULL
and	NULL
specific	NULL
protein	NULL
interactions	NULL
necessary	NULL
for	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
prointerleukin	NULL
1B	NULL
gene	NULL
.	NULL

A	NULL
cell-type-independent	NULL
lipopoly-saccharide	NULL
(	NULL
LPS	NULL
)	NULL
-responsive	NULL
enhancer	NULL
element	NULL
located	NULL
between	NULL
-3757	NULL
and	NULL
-2729	NULL
bp	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
cap	NULL
site	NULL
)	NULL
consisted	NULL
of	NULL
at	NULL
least	NULL
six	NULL
discrete	NULL
subregions	NULL
which	NULL
were	NULL
essential	NULL
to	NULL
the	NULL
maximal	NULL
induction	NULL
by	NULL
LPS	NULL
in	NULL
transfected	NULL
monocytes	NULL
.	NULL

The	NULL
enhancer	NULL
also	NULL
appeared	NULL
to	NULL
mediate	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
induction	NULL
in	NULL
monocytes	NULL
and	NULL
IL-1	NULL
responsiveness	NULL
in	NULL
fibroblasts	NULL
.	NULL

Deletion	NULL
and	NULL
base	NULL
substitution	NULL
mutations	NULL
along	NULL
with	NULL
DNA	NULL
binding	NULL
studies	NULL
demonstrated	NULL
that	NULL
the	NULL
enhancer	NULL
contained	NULL
a	NULL
minimum	NULL
of	NULL
three	NULL
functional	NULL
protein	NULL
binding	NULL
sequences	NULL
,	NULL
two	NULL
of	NULL
which	NULL
appeared	NULL
to	NULL
be	NULL
important	NULL
for	NULL
gene	NULL
induction	NULL
.	NULL

One	NULL
of	NULL
the	NULL
essential	NULL
proteins	NULL
which	NULL
bound	NULL
to	NULL
the	NULL
enhancer	NULL
was	NULL
similar	NULL
or	NULL
identical	NULL
to	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
required	NULL
for	NULL
both	NULL
IL-1-	NULL
and	NULL
LPS-specific	NULL
induction	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
the	NULL
NF-IL6	NULL
proteins	NULL
)	NULL
.	NULL

When	NULL
ligated	NULL
to	NULL
the	NULL
prolL-1B	NULL
cap	NULL
site-proximal	NULL
region	NULL
(	NULL
located	NULL
between	NULL
-131	NULL
to	NULL
+12	NULL
)	NULL
,	NULL
both	NULL
the	NULL
proIL-1B	NULL
and	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
enhancer	NULL
elements	NULL
functioned	NULL
more	NULL
efficiently	NULL
in	NULL
monocytes	NULL
than	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
not	NULL
normally	NULL
competent	NULL
for	NULL
IL-1B	NULL
expression	NULL
.	NULL

When	NULL
ligated	NULL
to	NULL
the	NULL
murine	NULL
c-fos	NULL
promoter	NULL
,	NULL
however	NULL
,	NULL
the	NULL
prolL-16B	NULL
enhancer	NULL
was	NULL
inducible	NULL
in	NULL
phorbol	NULL
myristate	NULL
acetate-stimulated	NULL
HeLa	NULL
cells	NULL
,	NULL
suggesting	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
prolL-1B	NULL
promoter-proximal	NULL
requirement	NULL
for	NULL
tissue	NULL
specificity	NULL
.	NULL

Interleukin	NULL
18	NULL
(	NULL
IL-1B	NULL
)	NULL
,	NULL
a	NULL
17-kDa	NULL
cytokine	NULL
involved	NULL
in	NULL
inflammatory	NULL
and	NULL
immunological	NULL
processes	NULL
,	NULL
is	NULL
produced	NULL
by	NULL
activated	NULL
monocytes/macrophages	NULL
,	NULL
fibroblasts	NULL
,	NULL
endothelial	NULL
cells	NULL
,	NULL
and	NULL
other	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
IL-1	NULL
proteins	NULL
are	NULL
translated	NULL
as	NULL
larger	NULL
31-kDa	NULL
precursors	NULL
(	NULL
proIL-1	NULL
)	NULL
which	NULL
are	NULL
extracellu-larly	NULL
processed	NULL
into	NULL
smaller	NULL
17-kDa	NULL
forms	NULL
(	NULL
mature	NULL
IL-1	NULL
)	NULL
(	NULL
4	NULL
,	NULL
20	NULL
)	NULL
.	NULL

There	NULL
are	NULL
two	NULL
prolIL-1	NULL
genes	NULL
(	NULL
proIL-la	NULL
«	NULL
and	NULL
proIL-1	NULL
$	NULL
B	NULL
)	NULL
coding	NULL
for	NULL
distinct	NULL
proteins	NULL
which	NULL
are	NULL
observed	NULL
in	NULL
many	NULL
different	NULL
species	NULL
(	NULL
7	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
two	NULL
prolIL-1	NULL
genes	NULL
are	NULL
located	NULL
on	NULL
human	NULL
chromosome	NULL
2	NULL
(	NULL
11	NULL
,	NULL
30	NULL
,	NULL
48	NULL
)	NULL
and	NULL
show	NULL
a	NULL
high	NULL
conservation	NULL
of	NULL
exon/intron	NULL
structure	NULL
(	NULL
7	NULL
)	NULL
.	NULL

IL-1	NULL
has	NULL
a	NULL
variety	NULL
of	NULL
biological	NULL
activities	NULL
on	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
tissues	NULL
(	NULL
see	NULL
reference	NULL
13	NULL
for	NULL
a	NULL
review	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
IL-1	NULL
induces	NULL
the	NULL
production	NULL
of	NULL
inflammatory	NULL
mediators	NULL
,	NULL
proteolytic	NULL
enzymes	NULL
,	NULL
and	NULL
other	NULL
cytokines	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
joint	NULL
destruction	NULL
and	NULL
inflammation	NULL
of	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
29	NULL
)	NULL
.	NULL

IL-1	NULL
also	NULL
modifies	NULL
connective	NULL
tissue	NULL
and	NULL
bone	NULL
metabolism	NULL
through	NULL
the	NULL
induction	NULL
and	NULL
type	NULL
switch	NULL
of	NULL
collagen	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
bone	NULL
resorption	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
proIL-1B	NULL
gene	NULL
is	NULL
normally	NULL
not	NULL
transcribed	NULL
in	NULL
competent	NULL
cells	NULL
until	NULL
activated	NULL
by	NULL
stimuli	NULL
such	NULL
as	NULL
lipopolysaccha-ride	NULL
(	NULL
LPS	NULL
)	NULL
or	NULL
phorbol	NULL
12-myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
or	NULL
by	NULL
17-kDa	NULL
IL-1B	NULL
protein	NULL
(	NULL
9	NULL
,	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

In	NULL
monocytes	NULL
stimulated	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

t	NULL
Present	NULL
address	NULL
:	NULL
First	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Occupational	NULL
and	NULL
Environmental	NULL
Health	NULL
,	NULL
Kitakyushu	NULL
,	NULL
807	NULL
Japan	NULL
.	NULL

1332	NULL
with	NULL
LPS	NULL
,	NULL
IL-1B	NULL
mRNA	NULL
is	NULL
rapidly	NULL
and	NULL
transiently	NULL
transcribed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
protein	NULL
synthesis	NULL
(	NULL
15	NULL
)	NULL
,	NULL
suggesting	NULL
the	NULL
activation	NULL
of	NULL
preexisting	NULL
transcription	NULL
factors	NULL
.	NULL

Our	NULL
previous	NULL
studies	NULL
revealed	NULL
the	NULL
importance	NULL
of	NULL
promoter	NULL
sequences	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
cap	NULL
site	NULL
)	NULL
(	NULL
3	NULL
,	NULL
8	NULL
,	NULL
10	NULL
,	NULL
14	NULL
,	NULL
24	NULL
,	NULL
26	NULL
)	NULL
in	NULL
regulating	NULL
proIL-1B	NULL
gene	NULL
expression	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
specific	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
requires	NULL
sequences	NULL
both	NULL
far	NULL
upstream	NULL
of	NULL
the	NULL
cap	NULL
site	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
first	NULL
intervening	NULL
sequence	NULL
(	NULL
3	NULL
,	NULL
5	NULL
)	NULL
.	NULL

The	NULL
far-upstream	NULL
sequences	NULL
described	NULL
by	NULL
Bensi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
5	NULL
)	NULL
define	NULL
a	NULL
PMA-responsive	NULL
enhancer	NULL
sequence	NULL
located	NULL
between	NULL
positions	NULL
-2982	NULL
and	NULL
-2795	NULL
.	NULL

Further	NULL
deletion	NULL
of	NULL
this	NULL
region	NULL
by	NULL
these	NULL
investigators	NULL
revealed	NULL
that	NULL
removal	NULL
of	NULL
sequences	NULL
either	NULL
between	NULL
-2982	NULL
and	NULL
-2929	NULL
or	NULL
between	NULL
-2877	NULL
and	NULL
-2795	NULL
abolished	NULL
gene	NULL
induction	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
LPS-responsive	NULL
region	NULL
maps	NULL
to	NULL
the	NULL
general	NULL
location	NULL
within	NULL
the	NULL
gene	NULL
previously	NULL
reported	NULL
for	NULL
PMA	NULL
induction	NULL
by	NULL
Bensi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
PMA-inducible	NULL
enhancer	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
LPS-responsive	NULL
region	NULL
(	NULL
located	NULL
between	NULL
-3757	NULL
and	NULL
-2729	NULL
)	NULL
extends	NULL
an	NULL
additional	NULL
150	NULL
to	NULL
775	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
PMA-sensitive	NULL
region	NULL
and	NULL
contains	NULL
discrete	NULL
cooperative	NULL
regions	NULL
which	NULL
provide	NULL
tissue-specific	NULL
expression	NULL
only	NULL
in	NULL
the	NULL
context	NULL
of	NULL
cap	NULL
site-proximal	NULL
proIL-1B	NULL
promoter	NULL
sequences	NULL
.	NULL

At	NULL
least	NULL
three	NULL
distinct	NULL
nuclear	NULL
factors	NULL
are	NULL
observed	NULL
to	NULL
bind	NULL
to	NULL
essential	NULL
regions	NULL
of	NULL
this	NULL
enhancer	NULL
.	NULL

Analyses	NULL
of	NULL
specific	NULL
nucleotide	NULL
substitutions	NULL
and	NULL
deletions	NULL
demonstrate	NULL
that	NULL
decreasing	NULL
the	NULL
binding	NULL
efficiency	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
for	NULL
at	NULL
least	NULL
two	NULL
of	NULL
these	NULL
factors	NULL
results	NULL
in	NULL
a	NULL
corresponding	NULL
decrease	NULL
in	NULL
LPS-dependent	NULL
gene	NULL
expression	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Endotoxin	NULL
tests	NULL
.	NULL

All	NULL
materials	NULL
and	NULL
solutions	NULL
,	NULL
including	NULL
plasmids	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
media	NULL
,	NULL
and	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
for	NULL
tissue	NULL
culture	NULL
and	NULL
transfection	NULL
,	NULL
were	NULL
tested	NULL
for	NULL
endotoxin	NULL
by	NULL
a	NULL
Limulus	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
(	NULL
QCL-1000	NULL
;	NULL
Whittaker	NULL
Bioproducts	NULL
,	NULL
Inc.	NULL
,	NULL
Walkersville	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

.	NULL

To	NULL
reduce	NULL
endotoxin	NULL
levels	NULL
,	NULL
glassware	NULL
and	NULL
CsCl	NULL
were	NULL
baked	NULL
and	NULL
sterile	NULL
irrigation	NULL
water	NULL
(	NULL
Baxter	NULL
Healthcare	NULL
Corp.	NULL
,	NULL
Deerfield	NULL
,	NULL
III	NULL
.	NULL
)	NULL

was	NULL
used	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
all	NULL
aqueous	NULL
solutions	NULL
.	NULL

Endotoxin	NULL
contamination	NULL
of	NULL
plasmids	NULL
,	NULL
PBS	NULL
,	NULL
media	NULL
,	NULL
and	NULL
FBS	NULL
was	NULL
also	NULL
monitored	NULL
by	NULL
Northern	NULL
(	NULL
RNA	NULL
)	NULL
dot	NULL
blot	NULL
analysis	NULL
using	NULL
IL-1B	NULL
cDNA	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Cell	NULL
lines	NULL
.	NULL

A	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
,	NULL
THP-1	NULL
(	NULL
ATCC	NULL
TIB	NULL
202	NULL
)	NULL
,	NULL
and	NULL
a	NULL
murine	NULL
macrophage	NULL
cell	NULL
line	NULL
,	NULL
RAW	NULL
264.7	NULL
(	NULL
ATCC	NULL
TIB	NULL
71	NULL
)	NULL
,	NULL
were	NULL
carefully	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium-25	NULL
mM	NULL
N-2-hydroxyethylpiperazine-N'-2-ethane-sulfonic	NULL
acid	NULL
(	NULL
HEPES	NULL
)	NULL
with	NULL
L-glutamine	NULL
(	NULL
0.08	NULL
endotoxin	NULL
unit/ml	NULL
;	NULL
Whittaker	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
FBS	NULL
(	NULL
defined	NULL
FBS	NULL
;	NULL
less	NULL
than	NULL
0.06	NULL
endotoxin	NULL
unit/ml	NULL
;	NULL
HyClone	NULL
Laboratories	NULL
,	NULL
Logan	NULL
,	NULL
Utah	NULL
)	NULL
and	NULL
0.5	NULL
%	NULL
penicillin-streptomycin	NULL
.	NULL

Cells	NULL
were	NULL
discarded	NULL
when	NULL
they	NULL
either	NULL
exhibited	NULL
morphological	NULL
changes	NULL
or	NULL
lost	NULL
their	NULL
LPS-dependent	NULL
IL-1B	NULL
mRNA	NULL
transcription	NULL
response	NULL
.	NULL

The	NULL
media	NULL
for	NULL
THP-1	NULL
cells	NULL
also	NULL
contained	NULL
5	NULL
x	NULL
10~*	NULL
M	NULL
2-mercaptoethanol	NULL
,	NULL
which	NULL
was	NULL
essential	NULL
for	NULL
cell	NULL
maintenance	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
.	NULL

RAW	NULL
264.7	NULL
cells	NULL
were	NULL
split	NULL
after	NULL
being	NULL
washed	NULL
with	NULL
PBS	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
in	NULL
PBS	NULL
containing	NULL
20	NULL
mM	NULL
EDTA	NULL
.	NULL

HeLa	NULL
cells	NULL
(	NULL
ATCC	NULL
CCL	NULL
2	NULL
)	NULL
and	NULL
human	NULL
foreskin	NULL
fibroblasts	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
(	NULL
DMEM	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
FBS	NULL
and	NULL
penicillin-streptomycin	NULL
.	NULL

Plasmids	NULL
.	NULL

Human	NULL
IL-1B	NULL
genomic	NULL
DNA	NULL
fragments	NULL
were	NULL
derived	NULL
from	NULL
clone	NULL
BDC454	NULL
(	NULL
7	NULL
)	NULL
and	NULL
inserted	NULL
into	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
plasmid	NULL
vectors	NULL
pA10OCAT3M	NULL
(	NULL
3M	NULL
)	NULL
,	NULL
pA10CAT3ME	NULL
(	NULL
3ME	NULL
)	NULL
(	NULL
31	NULL
)	NULL
,	NULL
and	NULL
fos	NULL
CAT	NULL
(	NULL
fos	NULL
)	NULL
(	NULL
33	NULL
)	NULL
.	NULL

The	NULL
nomenclature	NULL
used	NULL
for	NULL
the	NULL
various	NULL
proIL-1B	NULL
constructs	NULL
reflects	NULL
the	NULL
nature	NULL
of	NULL
inserted	NULL
fragments	NULL
.	NULL

In	NULL
this	NULL
nomenclature	NULL
,	NULL
letter	NULL
symbols	NULL
reflect	NULL
the	NULL
specific	NULL
restriction	NULL
enzyme	NULL
used	NULL
and	NULL
numerals	NULL
locate	NULL
the	NULL
endpoints	NULL
of	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
primers	NULL
.	NULL

For	NULL
example	NULL
,	NULL
P	NULL
;	NULL
T	NULL
represents	NULL
a	NULL
Pvull-Taql	NULL
fragment	NULL
,	NULL
whereas	NULL
-29871T	NULL
represents	NULL
a	NULL
fragment	NULL
derived	NULL
from	NULL
a	NULL
PCR	NULL
primer	NULL
starting	NULL
with	NULL
-2987	NULL
at	NULL
one	NULL
end	NULL
and	NULL
ending	NULL
with	NULL
a	NULL
Taql-digested	NULL
end	NULL
at	NULL
the	NULL
other	NULL
.	NULL

The	NULL
DNA	NULL
fragments	NULL
were	NULL
generated	NULL
either	NULL
by	NULL
restriction	NULL
endonuclease	NULL
digestion	NULL
or	NULL
by	NULL
using	NULL
PCR	NULL
primer	NULL
oligonucleotides	NULL
to	NULL
generate	NULL
deletions	NULL
or	NULL
site-directed	NULL
mutants	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
alkaline	NULL
lysis	NULL
plasmid	NULL
preparations	NULL
(	NULL
41	NULL
)	NULL
were	NULL
purified	NULL
twice	NULL
on	NULL
CsCl-ethidium	NULL
bromide	NULL
gradients	NULL
.	NULL

The	NULL
DNA	NULL
used	NULL
for	NULL
transfection	NULL
was	NULL
assayed	NULL
for	NULL
supercoiled	NULL
density	NULL
by	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Endotoxin	NULL
levels	NULL
of	NULL
each	NULL
batch	NULL
were	NULL
monitored	NULL
by	NULL
the	NULL
Limulus	NULL
assay	NULL
,	NULL
and	NULL
only	NULL
DNA	NULL
preparations	NULL
containing	NULL
less	NULL
than	NULL
0.03	NULL
endotoxin	NULL
unit/ug	NULL
were	NULL
used	NULL
.	NULL

DNA	NULL
sequencing	NULL
.	NULL

The	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-1B	NULL
gene	NULL
and	NULL
all	NULL
novel	NULL
CAT	NULL
constructs	NULL
were	NULL
sequenced	NULL
according	NULL
to	NULL
the	NULL
method	NULL
reported	NULL
by	NULL
Kraft	NULL
et	NULL
al	NULL
.	NULL

(	NULL
28	NULL
)	NULL
,	NULL
in	NULL
which	NULL
double-stranded	NULL
miniprep	NULL
DNA	NULL
was	NULL
directly	NULL
used	NULL
as	NULL
the	NULL
template	NULL
for	NULL
sequence	NULL
analysis	NULL
.	NULL

Transfection	NULL
.	NULL

RAW	NULL
264.7	NULL
cells	NULL
(	NULL
4	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
plate	NULL
)	NULL
,	NULL
HeLa	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
plate	NULL
)	NULL
,	NULL
or	NULL
human	NULL
foreskin	NULL
fibroblasts	NULL
(	NULL
10°	NULL
cells	NULL
per	NULL
plate	NULL
)	NULL
were	NULL
plated	NULL
in	NULL
100-mm-diameter	NULL
culture	NULL
plates	NULL
24	NULL
h	NULL
before	NULL
transfection	NULL
.	NULL

Immedi-	NULL
NF-IL6é	NULL
IS	NULL
IMPORTANT	NULL
FOR	NULL
proIL-1B	NULL
GENE	NULL
EXPRESSION	NULL
1333	NULL
ately	NULL
before	NULL
CaPO	NULL
,	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
10	NULL
ml	NULL
of	NULL
DMEM	NULL
three	NULL
times	NULL
and	NULL
incubated	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
DMEM	NULL
containing	NULL
10	NULL
%	NULL
FBS	NULL
and	NULL
penicillin-streptomycin	NULL
for	NULL
3	NULL
or	NULL
4	NULL
h.	NULL
The	NULL
transfection	NULL
was	NULL
accomplished	NULL
using	NULL
a	NULL
CaPO	NULL
,	NULL
mammalian	NULL
cell	NULL
transfection	NULL
kit	NULL
(	NULL
5	NULL
Prime-	NULL
>	NULL
3	NULL
Prime	NULL
,	NULL
Inc.	NULL
,	NULL
Boulder	NULL
,	NULL
Colo.	NULL
)	NULL
.	NULL

Twenty	NULL
micrograms	NULL
of	NULL
plasmid	NULL
was	NULL
gently	NULL
mixed	NULL
with	NULL
0.5	NULL
ml	NULL
of	NULL
2x	NULL
HEBS	NULL
(	NULL
50	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.05	NULL
]	NULL
,	NULL
1.5	NULL
mM	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
280	NULL
mM	NULL
NaCl	NULL
,	NULL
12	NULL
mM	NULL
glucose	NULL
)	NULL
and	NULL
62	NULL
pl	NULL
of	NULL
2	NULL
M	NULL
CaCl	NULL
;	NULL
in	NULL
1	NULL
ml	NULL
and	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
in	NULL
order	NULL
to	NULL
generate	NULL
a	NULL
fine	NULL
precipitate	NULL
,	NULL
which	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
.	NULL

The	NULL
plate	NULL
was	NULL
incubated	NULL
for	NULL
5	NULL
h	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
a	NULL
15	NULL
%	NULL
glycerol	NULL
shock	NULL
,	NULL
which	NULL
was	NULL
carried	NULL
out	NULL
for	NULL
approximately	NULL
2	NULL
to	NULL
3	NULL
min	NULL
,	NULL
depending	NULL
upon	NULL
cell	NULL
type	NULL
.	NULL

After	NULL
being	NULL
washed	NULL
with	NULL
10	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
medium	NULL
three	NULL
times	NULL
,	NULL
cells	NULL
were	NULL
then	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
or	NULL
DMEM	NULL
for	NULL
HeLa	NULL
cells	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
FBS	NULL
and	NULL
penicillin-streptomycin	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
18	NULL
h	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
LPS	NULL
(	NULL
Escherichia	NULL
coli	NULL
serotype	NULL
O55	NULL
:	NULL
B5	NULL
;	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

per	NULL
ml	NULL
for	NULL
an	NULL
additional	NULL
8	NULL
h	NULL
prior	NULL
to	NULL
harvest	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
DMEM	NULL
containing	NULL
10	NULL
%	NULL
FBS	NULL
and	NULL
penicillin-streptomycin	NULL
for	NULL
40	NULL
h	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
50	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
for	NULL
an	NULL
additional	NULL
24	NULL
h.	NULL
Fibroblasts	NULL
were	NULL
incubated	NULL
for	NULL
8	NULL
h	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
0.1	NULL
to	NULL
10	NULL
ng	NULL
of	NULL
human	NULL
recombinant	NULL
(	NULL
50	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
an	NULL
additional	NULL
15	NULL
h.	NULL
The	NULL
THP	NULL
-1	NULL
cells	NULL
were	NULL
plated	NULL
at	NULL
4	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
the	NULL
day	NULL
before	NULL
transfection	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
unsupplemented	NULL
RPMI	NULL
1640	NULL
prior	NULL
to	NULL
transfection	NULL
,	NULL
and	NULL
10	NULL
``	NULL
cells	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
the	NULL
same	NULL
medium	NULL
were	NULL
mixed	NULL
with	NULL
DEAE-DNA	NULL
transfection	NULL
solution	NULL
prepared	NULL
as	NULL
follows	NULL
:	NULL
10	NULL
ug	NULL
of	NULL
DNA	NULL
was	NULL
mixed	NULL
with	NULL
0.5	NULL
ml	NULL
of	NULL
1	NULL
M	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
and	NULL
7.5	NULL
ml	NULL
of	NULL
unsupplemented	NULL
RPMI	NULL
1640	NULL
,	NULL
mixed	NULL
well	NULL
,	NULL
and	NULL
added	NULL
to	NULL
1	NULL
ml	NULL
of	NULL
2-mg/ml	NULL
DEAE-dextran	NULL
(	NULL
~500,000	NULL
,	NULL
average	NULL
molecular	NULL
weight	NULL
;	NULL
Pharmacia	NULL
LKB	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
prior	NULL
to	NULL
centrifu-gation	NULL
and	NULL
resuspension	NULL
into	NULL
10	NULL
ml	NULL
of	NULL
unsupplemented	NULL
RPMI	NULL
1640	NULL
containing	NULL
1.5	NULL
U	NULL
of	NULL
heparin	NULL
sodium	NULL
(	NULL
Elkins-Sinn	NULL
,	NULL
Inc.	NULL
,	NULL
Cherry	NULL
Hill	NULL
,	NULL
N.J.	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
immediately	NULL
centrifuged	NULL
and	NULL
washed	NULL
in	NULL
unsupplemented	NULL
medium	NULL
prior	NULL
to	NULL
resuspension	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
complete	NULL
medium	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
in	NULL
10-cm-diameter	NULL
tissue	NULL
culture	NULL
dishes	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
£	NULL
.	NULL

coli	NULL
055	NULL
:	NULL
B5	NULL
;	NULL
10	NULL
ug/ml	NULL
;	NULL
Sigma	NULL
)	NULL
or	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
24	NULL
h	NULL
before	NULL
harvesting	NULL
.	NULL

CAT	NULL
assay	NULL
.	NULL

After	NULL
harvest	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
10	NULL
ml	NULL
of	NULL
PBS	NULL
twice	NULL
and	NULL
resuspended	NULL
in	NULL
150	NULL
pl	NULL
of	NULL
0.25	NULL
M	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
-0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
.	NULL

After	NULL
three	NULL
freeze-thaw	NULL
cycles	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
heat	NULL
inactivated	NULL
at	NULL
65°C	NULL
for	NULL
10	NULL
min	NULL
and	NULL
micro-centrifuged	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
supernatant	NULL
concentrations	NULL
were	NULL
measured	NULL
with	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
kit	NULL
.	NULL

The	NULL
CAT	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
a	NULL
liquid	NULL
scintillation	NULL
method	NULL
(	NULL
45	NULL
)	NULL
,	NULL
using	NULL
100	NULL
ug	NULL
of	NULL
THP-1	NULL
,	NULL
50	NULL
ug	NULL
of	NULL
RAW	NULL
264.7	NULL
,	NULL
and	NULL
100	NULL
ug	NULL
of	NULL
HeLa	NULL
cell	NULL
lysates	NULL
in	NULL
150	NULL
and	NULL
100	NULL
pl	NULL
of	NULL
a	NULL
mixture	NULL
of	NULL
2.5	NULL
mM	NULL
chloramphenicol	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
0.5	NULL
mCi	NULL
of	NULL
[	NULL
*HJacetyl	NULL
coen-zyme	NULL
A	NULL
(	NULL
NEN	NULL
)	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
evaluated	NULL
by	NULL
calculating	NULL
slopes	NULL
within	NULL
a	NULL
linear	NULL
range	NULL
of	NULL
the	NULL
response	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
method	NULL
previously	NULL
reported	NULL
(	NULL
12	NULL
,	NULL
37	NULL
,	NULL
44	NULL
)	NULL
,	NULL
with	NULL
modifications	NULL
.	NULL

After	NULL
a	NULL
45-min	NULL
incubation	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
pg/ml	NULL
or	NULL
1-h	NULL
incubation	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
,	NULL
1	NULL
x	NULL
10°	NULL
to	NULL
3	NULL
x	NULL
10	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
incubated	NULL
in	NULL
5	NULL
mi	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
at	NULL
4°C	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
10	NULL
mM	NULL
NaCl	NULL
,	NULL
0.3	NULL
M	NULL
sucrose	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
)	NULL
containing	NULL
1	NULL
mg	NULL
of	NULL
each	NULL
of	NULL
the	NULL
protease	NULL
inhibitors	NULL
1334	NULL
SHIRAKAWA	NULL
ET	NULL
AL	NULL
.	NULL

antipain	NULL
,	NULL
aprotinin	NULL
,	NULL
chymostatin	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
pepstatin	NULL
A	NULL
per	NULL
ml	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
to	NULL
10	NULL
min	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
1	NULL
mi	NULL
of	NULL
buffer	NULL
A	NULL
with	NULL
protease	NULL
inhibitors	NULL
and	NULL
then	NULL
Dounce	NULL
homogenized	NULL
.	NULL

The	NULL
homogenate	NULL
was	NULL
micro-centrifuged	NULL
for	NULL
30	NULL
s	NULL
,	NULL
and	NULL
nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
0.8	NULL
ml	NULL
of	NULL
buffer	NULL
B	NULL
with	NULL
protease	NULL
inhibitors	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
300	NULL
mM	NULL
KCI	NULL
,	NULL
0.2	NULL
mM	NULL
EGTA	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
)	NULL
and	NULL
gently	NULL
rocked	NULL
on	NULL
a	NULL
platform	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

After	NULL
30	NULL
min	NULL
of	NULL
microcentrifugation	NULL
at	NULL
4°C	NULL
,	NULL
supernatants	NULL
were	NULL
dialyzed	NULL
against	NULL
50	NULL
volumes	NULL
of	NULL
buffer	NULL
D	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
)	NULL
at	NULL
4°C	NULL
for	NULL
6	NULL
h	NULL
or	NULL
overnight	NULL
.	NULL

After	NULL
30	NULL
min	NULL
of	NULL
microcentrifugation	NULL
at	NULL
4°C	NULL
,	NULL
ali-quots	NULL
of	NULL
supernatants	NULL
were	NULL
frozen	NULL
at	NULL
-70°C	NULL
and	NULL
protein	NULL
concentrations	NULL
were	NULL
measured	NULL
by	NULL
using	NULL
a	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
kit	NULL
.	NULL

Preparation	NULL
of	NULL
radiolabeled	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
probes	NULL
.	NULL

Probes	NULL
were	NULL
labeled	NULL
by	NULL
filling	NULL
in	NULL
3	NULL
'	NULL
recessed	NULL
ends	NULL
by	NULL
using	NULL
DNA	NULL
polymerase	NULL
Klenow	NULL
fragment	NULL
and	NULL
all	NULL
four	NULL
a-*°P-labeled	NULL
deoxynucleoside	NULL
triphosphates	NULL
(	NULL
dNTPs	NULL
)	NULL
at	NULL
3,000	NULL
Ci/mmol	NULL
(	NULL
DuPont-NEN	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Unincorporated	NULL
dNTPs	NULL
were	NULL
removed	NULL
by	NULL
use	NULL
of	NULL
G-25	NULL
or	NULL
G-50	NULL
columns	NULL
(	NULL
5	NULL
Prime-	NULL
>	NULL
3	NULL
Prime	NULL
)	NULL
.	NULL

EMSA	NULL
.	NULL

EMSA	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
the	NULL
previously	NULL
reported	NULL
method	NULL
(	NULL
44	NULL
)	NULL
,	NULL
using	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.25	NULL
%	NULL
TAE	NULL
buffer	NULL
(	NULL
6.67	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.5	NULL
}	NULL
,	NULL
3.3	NULL
mM	NULL
sodium	NULL
acetate	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
15	NULL
ul	NULL
of	NULL
a	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
B-mercaptocthanol	NULL
,	NULL
4	NULL
%	NULL
glycerol	NULL
,	NULL
0	NULL
to	NULL
40	NULL
mM	NULL
NaCl	NULL
for	NULL
different	NULL
probes	NULL
)	NULL
containing	NULL
probe	NULL
(	NULL
0.2	NULL
ng	NULL
,	NULL
5,000	NULL
to	NULL
20,000	NULL
cpm	NULL
)	NULL
,	NULL
0.2	NULL
to	NULL
0.8	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
6	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
run	NULL
at	NULL
4°C	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
accession	NULL
number	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
data	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
have	NULL
been	NULL
submitted	NULL
to	NULL
GenBank	NULL
and	NULL
assigned	NULL
accession	NULL
number	NULL
LO6808	NULL
.	NULL

RESULTS	NULL
Identification	NULL
of	NULL
an	NULL
upstream	NULL
region	NULL
required	NULL
for	NULL
LPS	NULL
induction	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
sequence	NULL
requirements	NULL
for	NULL
prolL-1B	NULL
gene	NULL
transcription	NULL
,	NULL
transiently	NULL
transfected	NULL
CAT	NULL
constructs	NULL
which	NULL
contained	NULL
variable	NULL
lengths	NULL
of	NULL
upstream	NULL
sequence	NULL
were	NULL
introduced	NULL
into	NULL
monocyte	NULL
cell	NULL
lines	NULL
.	NULL

We	NULL
previously	NULL
showed	NULL
that	NULL
LPS	NULL
was	NULL
capable	NULL
of	NULL
generating	NULL
at	NULL
least	NULL
a	NULL
10-fold	NULL
stimulation	NULL
of	NULL
the	NULL
endogenous	NULL
gene	NULL
in	NULL
intact	NULL
cells	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Our	NULL
earlier	NULL
reports	NULL
on	NULL
proIL-18B	NULL
gene	NULL
transcription	NULL
in	NULL
transfected	NULL
human	NULL
THP-1	NULL
monocytic	NULL
cells	NULL
suggested	NULL
that	NULL
DNA	NULL
sequences	NULL
located	NULL
between	NULL
-1097	NULL
and	NULL
+384	NULL
in	NULL
the	NULL
human	NULL
proIL-1f	NULL
gene	NULL
were	NULL
not	NULL
capable	NULL
of	NULL
supporting	NULL
a	NULL
strong	NULL
transcriptional	NULL
induction	NULL
by	NULL
LPS	NULL
(	NULL
3	NULL
,	NULL
8	NULL
)	NULL
.	NULL

We	NULL
have	NULL
now	NULL
extended	NULL
our	NULL
upstream	NULL
clones	NULL
beyond	NULL
those	NULL
previously	NULL
reported	NULL
(	NULL
constructs	NULL
PT	NULL
,	NULL
AT	NULL
,	NULL
DT	NULL
,	NULL
NT	NULL
,	NULL
and	NULL
HT	NULL
[	NULL
8	NULL
]	NULL
)	NULL
to	NULL
include	NULL
new	NULL
CAT	NULL
constructs	NULL
terminating	NULL
almost	NULL
4	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

In	NULL
contrast	NULL
with	NULL
our	NULL
earlier	NULL
studies	NULL
,	NULL
which	NULL
used	NULL
THP-1	NULL
human	NULL
monocyte	NULL
cell	NULL
lines	NULL
,	NULL
the	NULL
murine	NULL
monocyte	NULL
cell	NULL
line	NULL
RAW	NULL
264.7	NULL
(	NULL
38	NULL
)	NULL
was	NULL
used	NULL
.	NULL

This	NULL
cell	NULL
line	NULL
was	NULL
chosen	NULL
for	NULL
our	NULL
studies	NULL
because	NULL
we	NULL
observed	NULL
that	NULL
calcium	NULL
phosphate	NULL
transfection	NULL
of	NULL
these	NULL
cells	NULL
does	NULL
not	NULL
result	NULL
in	NULL
proIL-1B	NULL
gene	NULL
transcription	NULL
and	NULL
that	NULL
a	NULL
15-kb	NULL
human	NULL
proIL-1B	NULL
gene	NULL
corresponding	NULL
to	NULL
the	NULL
entire	NULL
prolIL-1f	NULL
structural	NULL
gene	NULL
and	NULL
flanking	NULL
sequences	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
DNA	NULL
located	NULL
between	NULL
the	NULL
previously	NULL
described	NULL
upstream	NULL
EcoRI	NULL
site	NULL
and	NULL
the	NULL
downstream	NULL
Sa/l	NULL
site	NULL
in	NULL
clone	NULL
BDC-454	NULL
[	NULL
7	NULL
]	NULL
)	NULL
is	NULL
regulated	NULL
in	NULL
a	NULL
manner	NULL
which	NULL
is	NULL
indistinguishable	NULL
from	NULL
that	NULL
of	NULL
the	NULL
endogenous	NULL
murine	NULL
gene	NULL
Mor	NULL
.	NULL

Cer	NULL
.	NULL

Bro..	NULL
«	NULL
3757	NULL
TCTAGACCAG	NULL
GGAGGAGAAT	NULL
GGAATGTCCC	NULL
TTGGACTCTG	NULL
CAT	NULL
@	NULL
TCCCCA	NULL
3707	NULL
ATCTGAGAAC	NULL
CTGGATCCAA	NULL
GAGGGAGAAG	NULL
AAGCCCATTG	NULL
GAGATGATGC	NULL
«	NULL
3657	NULL
-	NULL
CATAAAGGAA	NULL
GTGGAAGCGA	NULL
TATGATAAAA	NULL
ATCATAGTGC	NULL
CCATTCCCAA	NULL
-3607	NULL
ATAATCCCAG	NULL
AAGCAGAAGG	NULL
GAAAGGAGAG	NULL
AAATATCACA	NULL
AAGACAGGTG	NULL
«	NULL
3557	NULL
-	NULL
TGGGTACACA	NULL
CAACATTTTT	NULL
TCATACCTTT	NULL
AAGATCCCAG	NULL
AGGACTCATG	NULL
3507	NULL
GAAATGATAC	NULL
AGAAATGACC	NULL
TCATAAGAAC	NULL
AATATTAGGA	NULL
AGCCAGTCCA	NULL
3457	NULL
AGAATGAGAT	NULL
GGGAAATTGG	NULL
GGAAAATGTT	NULL
GGGGGCAGAT	NULL
TGCTTAGTITC	NULL
3407	NULL
-	NULL
TGTTCCTAAG	NULL
CAAGAGGGTG	NULL
ACCAAGAAGG	NULL
AACAGCTCAC	NULL
TACAAGACAG	NULL
3357	NULL
ACATCACTGC	NULL
ATGTACACAC	NULL
AATAATATAA	NULL
GAACTAACCC	NULL
AégATTATTT	NULL
«	NULL
3307	NULL
TGCTTGTCTT	NULL
CTTGTTCAAA	NULL
ATGATTGAAA	NULL
CCAATGAGAT	NULL
GAGTGATCAA	NULL
3257	NULL
CCTTGATAAC	NULL
TGGCTGCGAA	NULL
glgECCATGATT	NULL
AGACACAAGA	NULL
TGG	NULL
@	NULL
TATCAGG	NULL
3207	NULL
GCACTTGCTG	NULL
CTTTGéUH	NULL
’	NULL
AA	NULL
ATGTgeEITCT	NULL
CCT	NULL
@	NULL
TCTTGG	NULL
AAGAAJEACC	NULL
-3157	NULL
CTGACAGGGT	NULL
AAAGAGGAAC	NULL
TTGCAGCTGA	NULL
GAAAGGCTTT	NULL
AGTGACTCAA	NULL
3107	NULL
GAGCTGAATA	NULL
ATTCCCCAAA	NULL
AGCTGGAGCA	NULL
TCCTGGCATT	NULL
TCCAGCTCCC	NULL
3057	NULL
CATCTCTGCT	NULL
TGTTCCACTT	NULL
CCTTGGGGCT	NULL
ACATCACCAT	NULL
CTACATCATC	NULL
3007	NULL
ATCACTCTTC	NULL
CACTCCCTCC	NULL
CTTAGTGCCA	NULL
ACTATGTTTA	NULL
TAGCGAGATA	NULL
«	NULL
2957	NULL
TTTTCTGCTC	NULL
ATTGGGGATC	NULL
GGAAGGAAGT	NULL
NianGTGGCCT	NULL
GAGCGgECTC	NULL
2907	NULL
CTTGGGAAGA	NULL
CAGGATCTGA	NULL
TACATACGTT	NULL
GCACAACCTA	NULL
TTTGACATAA	NULL
CK-1	NULL
NFB	NULL
NE-B2	NULL
«	NULL
2857	NULL
GAGGTTTCAC	NULL
TTCCTGAGAT	NULL
GGATGGGATG	NULL
GTAGCAGATT	NULL
TGGG	NULL
@	NULL
TCCAGG	NULL
CRE/AP-1	NULL
2807	NULL
TTACNéGgGCC	NULL
AGGATGAGAC	NULL
ATGGCAGAACXgot'liTGGAGACT	NULL
GTTACGTCAG	NULL
ars	NULL
?	NULL

GGGGCATTGC	NULL
CATGGCTCCA	NULL
AAATTTCCCT	NULL
CGAGceAAAC	NULL
«	NULL
are	NULL
?	NULL

TCATGCAACC	NULL
TegaTACTAG	NULL
TecTtectTca	NULL
ACcAcAacteT	NULL
GCTATTGGAT	NULL
esr	NULL
caccetcerAa	NULL
ecctteattt	NULL
CtTceTcree	NULL
TeTTcacaTT	NULL
2607	NULL
-	NULL
CAAATAGCTA	NULL
TTCATGTCTT	NULL
CatCTcteTe	NULL
@	NULL
Tcccaccat	NULL
ATtccecaccae	NULL
2557	NULL
-	NULL
ACAATCATTA	NULL
GGGCTCCTCT	NULL
TAGCTGGCAG	NULL
ATTCTGAGeT	NULL
ccTtecaTGct	NULL
2507	NULL
ACAATTGGAA	NULL
GATGGAGAAG	NULL
TAGAAGCTCA	NULL
AcG	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Upstream	NULL
nucleic	NULL
acid	NULL
sequence	NULL
for	NULL
the	NULL
human	NULL
proIL-1f	NULL
gene	NULL
.	NULL

The	NULL
numbering	NULL
used	NULL
is	NULL
aligned	NULL
with	NULL
position	NULL
-2987	NULL
in	NULL
the	NULL
partial	NULL
sequence	NULL
reported	NULL
by	NULL
Bensi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
5	NULL
)	NULL
.	NULL

Specific	NULL
sequence	NULL
motifs	NULL
are	NULL
indicated	NULL
by	NULL
labeled	NULL
overbars	NULL
as	NULL
follows	NULL
:	NULL
dotted	NULL
bars	NULL
,	NULL
reference	NULL
restriction	NULL
enzyme	NULL
sites	NULL
;	NULL
solid	NULL
bars	NULL
,	NULL
experimentally	NULL
determined	NULL
protein	NULL
binding	NULL
sites	NULL
;	NULL
and	NULL
gray	NULL
bars	NULL
,	NULL
potential	NULL
protein	NULL
binding	NULL
sites	NULL
.	NULL

A	NULL
bold	NULL
solid	NULL
underbar	NULL
locates	NULL
the	NULL
site	NULL
of	NULL
a	NULL
single	NULL
IRF-1	NULL
hexamer	NULL
motif	NULL
within	NULL
the	NULL
B1	NULL
site	NULL
.	NULL

Abbreviations	NULL
for	NULL
potential	NULL
site	NULL
names	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
CRE	NULL
,	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
;	NULL
CK-1	NULL
,	NULL
cytokine	NULL
gene	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
(	NULL
43	NULL
)	NULL
;	NULL
AP-1	NULL
,	NULL
Fos/Jun	NULL
binding	NULL
site	NULL
;	NULL
and	NULL
Spi-1	NULL
,	NULL
Spi-1/PU.1	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
remaining	NULL
factors	NULL
NF-B1	NULL
,	NULL
NF-B2	NULL
,	NULL
and	NULL
NF-IL6	NULL
are	NULL
described	NULL
in	NULL
the	NULL
text	NULL
.	NULL

when	NULL
stably	NULL
introduced	NULL
into	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Our	NULL
earlier	NULL
work	NULL
suggested	NULL
a	NULL
link	NULL
between	NULL
the	NULL
method	NULL
of	NULL
THP-1	NULL
transfection	NULL
and	NULL
gene	NULL
induction	NULL
(	NULL
3	NULL
,	NULL
8	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
we	NULL
have	NULL
now	NULL
found	NULL
that	NULL
electroporation	NULL
of	NULL
these	NULL
cells	NULL
resulted	NULL
in	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
proIL-1B	NULL
gene	NULL
and	NULL
a	NULL
desensitization	NULL
from	NULL
further	NULL
induction	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
stimulant	NULL
such	NULL
as	NULL
LPS	NULL
or	NULL
PMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
have	NULL
more	NULL
recently	NULL
determined	NULL
that	NULL
DEAE-dextran	NULL
can	NULL
be	NULL
used	NULL
to	NULL
efficiently	NULL
transfect	NULL
THP	NULL
cells	NULL
without	NULL
significant	NULL
proIL-1fB	NULL
gene	NULL
induction	NULL
(	NULL
24	NULL
,	NULL
26	NULL
)	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
,	NULL
we	NULL
are	NULL
now	NULL
able	NULL
to	NULL
examine	NULL
the	NULL
specific	NULL
induction	NULL
of	NULL
this	NULL
gene	NULL
in	NULL
the	NULL
milieu	NULL
of	NULL
a	NULL
human	NULL
cell	NULL
line	NULL
in	NULL
which	NULL
we	NULL
have	NULL
previously	NULL
studied	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
gene	NULL
.	NULL

The	NULL
portion	NULL
of	NULL
the	NULL
human	NULL
proIL-1B	NULL
genomic	NULL
sequence	NULL
between	NULL
the	NULL
Xbal	NULL
site	NULL
at	NULL
-3757	NULL
and	NULL
position	NULL
-2475	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

This	NULL
sequence	NULL
extends	NULL
that	NULL
which	NULL
we	NULL
previously	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
NF-IL6	NULL
IS	NULL
IMPORTANT	NULL
FOR	NULL
proIL-18	NULL
GENE	NULL
EXPRESSION	NULL
1335	NULL
-2923	NULL
Drai	NULL
Hind1H	NULL
-313	NULL
-29087|	NULL
-2795	NULL
(	NULL
)	NULL
tn	NULL
{	NULL
+1	NULL
TT	NULL
I	NULL
A	NULL
BC	NULL
|	NULL
NsA	NULL
(	NULL
-234	NULL
)	NULL
Xbal	NULL
Pyull	NULL
Xhol	NULL
Pvull	NULL
Avai	NULL
Taq\	NULL
Average	NULL
CAT	NULL
Activity	NULL
(	NULL
-3757	NULL
)	NULL
(	NULL
-3132	NULL
)	NULL
(	NULL
-2729	NULL
)	NULL
(	NULL
-1097	NULL
)	NULL
|	NULL
(	NULL
-512	NULL
)	NULL
(	NULL
+12	NULL
)	NULL
0	NULL
100	NULL
200	NULL
xt	NULL
P	NULL
[	NULL
CAT	NULL
]	NULL
PgT	NULL
|	NULL
CAT	NULL
,	NULL
+29877	NULL
|	NULL
CAT	NULL
,	NULL
-29237	NULL
|	NULL
[	NULL
CAT	NULL
]	NULL
-279571	NULL
|	NULL
[	NULL
CAT	NULL
]	NULL
XhoT	NULL
}	NULL
CAT	NULL
PT	NULL
AT	NULL
DT	NULL
Blu	NULL
NT	NULL
(	NULL
CAT	NULL
HT	NULL
|	NULL
{	NULL
[	NULL
CAT	NULL
P	NULL
,	NULL
Xho/PT	NULL
Imm	NULL
}	NULL
~-	NULL
~~~	NULL
A1	NULL
]	NULL
Py	NULL
Xho/HT	NULL
=n	NULL
nnn	NULL
nn	NULL
ttt	NULL
TT	NULL
pA10CAT3M	NULL
Vector	NULL
-	NULL
[	NULL
CAT	NULL
]	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Summary	NULL
of	NULL
CAT	NULL
data	NULL
for	NULL
proIL-1B	NULL
gene	NULL
deletions	NULL
transfected	NULL
into	NULL
murine	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

Specific	NULL
proIL-18B	NULL
gene	NULL
sequences	NULL
(	NULL
horizontal	NULL
bars	NULL
)	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
coding	NULL
sequence	NULL
of	NULL
the	NULL
3M	NULL
vector	NULL
are	NULL
aligned	NULL
with	NULL
a	NULL
schematic	NULL
locating	NULL
specific	NULL
restriction	NULL
enzyme	NULL
sites	NULL
(	NULL
enzyme	NULL
names	NULL
and	NULL
locations	NULL
as	NULL
indicated	NULL
)	NULL
and	NULL
synthetic	NULL
PCR	NULL
primers	NULL
(	NULL
locations	NULL
indicated	NULL
)	NULL
.	NULL

The	NULL
schematic	NULL
also	NULL
shows	NULL
the	NULL
location	NULL
of	NULL
the	NULL
P	NULL
;	NULL
Xho	NULL
fragment	NULL
(	NULL
open	NULL
box	NULL
)	NULL
described	NULL
in	NULL
the	NULL
text	NULL
and	NULL
in	NULL
subsequent	NULL
figures	NULL
as	NULL
well	NULL
as	NULL
the	NULL
location	NULL
of	NULL
an	NULL
NF-IL6-like	NULL
binding	NULL
sequence	NULL
(	NULL
solid	NULL
circle	NULL
)	NULL
.	NULL

The	NULL
histogram	NULL
presents	NULL
uninduced	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
and	NULL
LPS-induced	NULL
(	NULL
solid	NULL
bars	NULL
)	NULL
CAT	NULL
data	NULL
represented	NULL
as	NULL
the	NULL
mean	NULL
of	NULL
the	NULL
slopes	NULL
for	NULL
plots	NULL
of	NULL
time	NULL
versus	NULL
counts	NULL
per	NULL
minute	NULL
.	NULL

The	NULL
value	NULL
for	NULL
each	NULL
construct	NULL
represents	NULL
results	NULL
from	NULL
a	NULL
minimum	NULL
of	NULL
two	NULL
experiments	NULL
(	NULL
average	NULL
was	NULL
five	NULL
experiments	NULL
)	NULL
with	NULL
an	NULL
average	NULL
deviation	NULL
of	NULL
55	NULL
%	NULL
.	NULL

reported	NULL
(	NULL
7	NULL
)	NULL
and	NULL
contains	NULL
several	NULL
potential	NULL
transcription	NULL
factor	NULL
binding	NULL
site	NULL
motifs	NULL
.	NULL

The	NULL
sequence	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
facilitated	NULL
the	NULL
synthesis	NULL
of	NULL
oligonucleotide	NULL
primers	NULL
which	NULL
were	NULL
used	NULL
to	NULL
generate	NULL
some	NULL
of	NULL
the	NULL
CAT	NULL
constructs	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
using	NULL
recombinant	NULL
PCR	NULL
synthesis	NULL
.	NULL

Specific	NULL
fragments	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
promoterless	NULL
3M	NULL
vector	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

The	NULL
progressive	NULL
series	NULL
of	NULL
upstream	NULL
end	NULL
deletions	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
shows	NULL
that	NULL
an	NULL
LPS-dependent	NULL
transcriptional	NULL
response	NULL
in	NULL
murine	NULL
RAW	NULL
264.7	NULL
cells	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
DNA	NULL
sequences	NULL
located	NULL
between	NULL
the	NULL
Xbal	NULL
site	NULL
at	NULL
-3757	NULL
and	NULL
position	NULL
-2923	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
constructs	NULL
used	NULL
in	NULL
this	NULL
study	NULL
,	NULL
these	NULL
sequences	NULL
were	NULL
delineated	NULL
into	NULL
three	NULL
functional	NULL
induction-specific	NULL
regions	NULL
.	NULL

The	NULL
first	NULL
region	NULL
,	NULL
located	NULL
between	NULL
-3757	NULL
and	NULL
-3132	NULL
(	NULL
region	NULL
A	NULL
)	NULL
,	NULL
appeared	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
approximately	NULL
20	NULL
%	NULL
of	NULL
the	NULL
LPS-inducible	NULL
activity	NULL
,	NULL
and	NULL
a	NULL
second	NULL
region	NULL
,	NULL
between	NULL
-3132	NULL
and	NULL
-2987	NULL
(	NULL
region	NULL
B	NULL
)	NULL
,	NULL
appeared	NULL
to	NULL
correlate	NULL
with	NULL
60	NULL
%	NULL
of	NULL
the	NULL
activity	NULL
.	NULL

The	NULL
third	NULL
region	NULL
,	NULL
located	NULL
between	NULL
-2987	NULL
and	NULL
-2923	NULL
(	NULL
region	NULL
C	NULL
)	NULL
,	NULL
appeared	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
an	NULL
additional	NULL
20	NULL
%	NULL
of	NULL
the	NULL
activity	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
demonstrated	NULL
that	NULL
the	NULL
-3132	NULL
to	NULL
-2923	NULL
sequence	NULL
(	NULL
regions	NULL
B	NULL
and	NULL
C	NULL
)	NULL
is	NULL
a	NULL
necessary	NULL
component	NULL
in	NULL
LPS-specific	NULL
induction	NULL
and	NULL
that	NULL
the	NULL
sequence	NULL
between	NULL
-3757	NULL
and	NULL
-3132	NULL
(	NULL
region	NULL
A	NULL
)	NULL
was	NULL
essential	NULL
for	NULL
maximal	NULL
activity	NULL
.	NULL

These	NULL
data	NULL
do	NULL
not	NULL
reveal	NULL
,	NULL
however	NULL
,	NULL
whether	NULL
regions	NULL
B	NULL
and	NULL
C	NULL
are	NULL
sufficient	NULL
for	NULL
induction	NULL
,	NULL
since	NULL
regions	NULL
downstream	NULL
of	NULL
-2923	NULL
may	NULL
be	NULL
necessary	NULL
but	NULL
insufficient	NULL
for	NULL
the	NULL
response	NULL
.	NULL

The	NULL
upstream	NULL
LPS	NULL
induction	NULL
region	NULL
reveals	NULL
internal	NULL
coop-erativity	NULL
,	NULL
To	NULL
address	NULL
the	NULL
possible	NULL
involvement	NULL
of	NULL
sequences	NULL
downstream	NULL
of	NULL
-2923	NULL
in	NULL
LPS	NULL
induction	NULL
,	NULL
sequences	NULL
between	NULL
-3132	NULL
and	NULL
+12	NULL
were	NULL
further	NULL
tested	NULL
by	NULL
introducing	NULL
internal	NULL
deletions	NULL
downstream	NULL
of	NULL
the	NULL
PvuII	NULL
site	NULL
at	NULL
-2729	NULL
.	NULL

The	NULL
-3132	NULL
upstream	NULL
terminus	NULL
was	NULL
chosen	NULL
because	NULL
a	NULL
majority	NULL
of	NULL
the	NULL
LPS	NULL
induction	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
mapped	NULL
between	NULL
the	NULL
Pvull	NULL
site	NULL
and	NULL
the	NULL
Tagl	NULL
site	NULL
at	NULL
+12	NULL
(	NULL
construct	NULL
P	NULL
;	NULL
T	NULL
)	NULL
.	NULL

Internal	NULL
deletions	NULL
located	NULL
between	NULL
the	NULL
Xhol	NULL
site	NULL
at	NULL
-2729	NULL
and	NULL
the	NULL
functional	NULL
prolL-1f	NULL
promoter	NULL
(	NULL
8	NULL
,	NULL
24	NULL
)	NULL
were	NULL
constructed	NULL
in	NULL
the	NULL
3M	NULL
vector	NULL
system	NULL
(	NULL
constructs	NULL
P	NULL
;	NULL
Xho/PT	NULL
and	NULL
P	NULL
;	NULL
Xho/HT	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
these	NULL
constructs	NULL
into	NULL
RAW	NULL
264.7	NULL
cells	NULL
revealed	NULL
that	NULL
although	NULL
downstream	NULL
sequences	NULL
between	NULL
-2729	NULL
and	NULL
-131	NULL
might	NULL
be	NULL
essential	NULL
for	NULL
maximal	NULL
induction	NULL
,	NULL
they	NULL
were	NULL
not	NULL
necessary	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
the	NULL
induction	NULL
signal	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
3M	NULL
-	NULL
P	NULL
;	NULL
Xho/PT	NULL
and	NULL
3M	NULL
-	NULL
P	NULL
;	NULL
Xho/HT	NULL
)	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
conclusion	NULL
,	NULL
when	NULL
the	NULL
Pvull-to-Xhol	NULL
(	NULL
P	NULL
,	NULL
;	NULL
,	NULL
Xho	NULL
)	NULL
fragment	NULL
was	NULL
tested	NULL
independently	NULL
of	NULL
the	NULL
proIL-18	NULL
promoter-proximal	NULL
DNA	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
by	NULL
the	NULL
use	NULL
of	NULL
a	NULL
murine	NULL
c-fos	NULL
promoter	NULL
,	NULL
the	NULL
level	NULL
of	NULL
LPS	NULL
induction	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
construct	NULL
3M	NULL
-	NULL
XT	NULL
(	NULL
compare	NULL
3M	NULL
-	NULL
XT	NULL
with	NULL
P	NULL
;	NULL
Xho/fos	NULL
in	NULL
the	NULL
data	NULL
for	NULL
RAW	NULL
264.7	NULL
cells	NULL
presented	NULL
in	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
P	NULL
;	NULL
Xho/fos	NULL
CAT	NULL
construct	NULL
was	NULL
used	NULL
to	NULL
derive	NULL
a	NULL
series	NULL
of	NULL
additional	NULL
constructs	NULL
designed	NULL
to	NULL
further	NULL
characterize	NULL
the	NULL
proIL-1B	NULL
enhancer	NULL
region	NULL
.	NULL

The	NULL
fos	NULL
CAT	NULL
vector	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
reveal	NULL
that	NULL
the	NULL
sequence	NULL
located	NULL
between	NULL
-3132	NULL
and	NULL
-2729	NULL
(	NULL
construct	NULL
2	NULL
,	NULL
P	NULL
;	NULL
Xho	NULL
)	NULL
generated	NULL
a	NULL
large	NULL
relative	NULL
LPS-induced	NULL
activity	NULL
when	NULL
transfected	NULL
either	NULL
into	NULL
RAW	NULL
264.7	NULL
or	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
additional	NULL
sequence	NULL
in	NULL
construct	NULL
1	NULL
between	NULL
-2729	NULL
and	NULL
-2599	NULL
(	NULL
region	NULL
J	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
yielded	NULL
a	NULL
reduced	NULL
activity	NULL
which	NULL
suggested	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
.	NULL

The	NULL
sequence	NULL
between	NULL
-3132	NULL
and	NULL
-2987	NULL
(	NULL
region	NULL
B	NULL
)	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
P	NULL
;	NULL
Xho/fos	NULL
CAT	NULL
construct	NULL
appeared	NULL
to	NULL
be	NULL
essential	NULL
(	NULL
compare	NULL
constructs	NULL
2	NULL
and	NULL
1336	NULL
SHIRAKAWA	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

TABLE	NULL
1	NULL
.	NULL

Summary	NULL
of	NULL
CAT	NULL
data	NULL
for	NULL
proIL-1B	NULL
constructs	NULL
transfected	NULL
into	NULL
THP-1	NULL
and	NULL
RAW	NULL
264.7	NULL
cells	NULL
Cell	NULL
line	NULL
CAT	NULL
construct	NULL
ProIL-18	NULL
DNA	NULL
CAT	NULL
activity	NULL
``	NULL
transfected	NULL
positions	NULL
Uninduced	NULL
LPS	NULL
induced	NULL
RAW	NULL
264.7	NULL
P	NULL
;	NULL
Xho/fos	NULL
-3132	NULL
to	NULL
-2729	NULL
46	NULL
+	NULL
28	NULL
(	NULL
10	NULL
)	NULL
280	NULL
+	NULL
70	NULL
(	NULL
10	NULL
)	NULL
3M	NULL
-	NULL
XT	NULL
-3757	NULL
to	NULL
+12	NULL
19	NULL
+	NULL
9	NULL
(	NULL
5	NULL
)	NULL
209	NULL
+	NULL
38	NULL
(	NULL
5	NULL
)	NULL
THP-1	NULL
P	NULL
;	NULL
Xho/fos	NULL
-3132	NULL
to	NULL
-2729	NULL
9	NULL
+	NULL
6	NULL
(	NULL
5	NULL
)	NULL
79	NULL
+	NULL
#	NULL
38	NULL
(	NULL
5	NULL
)	NULL
3M	NULL
-	NULL
P	NULL
,	NULL
T	NULL
-3132	NULL
to	NULL
+12	NULL
9	NULL
+	NULL
2	NULL
(	NULL
2	NULL
)	NULL
10	NULL
+	NULL
2	NULL
(	NULL
2	NULL
)	NULL
3M	NULL
-	NULL
P	NULL
;	NULL
Xho/PT	NULL
-3132	NULL
to	NULL
-2729	NULL
14	NULL
+	NULL
4	NULL
(	NULL
3	NULL
)	NULL
16	NULL
+	NULL
4	NULL
(	NULL
3	NULL
)	NULL
-1097	NULL
to	NULL
+12	NULL
``	NULL
Represented	NULL
as	NULL
the	NULL
mean	NULL
of	NULL
the	NULL
slopes	NULL
for	NULL
plots	NULL
of	NULL
time	NULL
versus	NULL
counts	NULL
per	NULL
minute	NULL
+	NULL
standard	NULL
deviation	NULL
.	NULL

Numbers	NULL
in	NULL
parentheses	NULL
represent	NULL
the	NULL
number	NULL
of	NULL
experiments	NULL
performed	NULL
.	NULL

3	NULL
with	NULL
construct	NULL
8	NULL
)	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
upstream	NULL
deletion	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

However	NULL
,	NULL
the	NULL
importance	NULL
of	NULL
this	NULL
region	NULL
was	NULL
not	NULL
as	NULL
great	NULL
when	NULL
sequences	NULL
between	NULL
-2780	NULL
to	NULL
-2599	NULL
(	NULL
region	NULL
I+J	NULL
)	NULL
were	NULL
present	NULL
(	NULL
compare	NULL
construct	NULL
2	NULL
with	NULL
constructs	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
thus	NULL
suggesting	NULL
that	NULL
region	NULL
I+	NULL
]	NULL
can	NULL
functionally	NULL
compensate	NULL
in	NULL
part	NULL
for	NULL
the	NULL
absence	NULL
of	NULL
region	NULL
B	NULL
.	NULL

Furthermore	NULL
,	NULL
as	NULL
demonstrated	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
DNA	NULL
sequence	NULL
located	NULL
between	NULL
-2894	NULL
and	NULL
-2729	NULL
(	NULL
regions	NULL
E	NULL
through	NULL
I	NULL
)	NULL
was	NULL
important	NULL
for	NULL
full	NULL
LPS-dependent	NULL
activity	NULL
(	NULL
constructs	NULL
3	NULL
through	NULL
6	NULL
)	NULL
,	NULL
and	NULL
the	NULL
sequence	NULL
between	NULL
-2894	NULL
and	NULL
-2864	NULL
(	NULL
region	NULL
E	NULL
)	NULL
appeared	NULL
to	NULL
be	NULL
a	NULL
significant	NULL
functional	NULL
component	NULL
of	NULL
this	NULL
region	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
this	NULL
30-bp-long	NULL
sequence	NULL
was	NULL
further	NULL
substantiated	NULL
by	NULL
an	NULL
internal	NULL
deletion	NULL
(	NULL
construct	NULL
10	NULL
)	NULL
.	NULL

However	NULL
,	NULL
although	NULL
necessary	NULL
,	NULL
region	NULL
E	NULL
was	NULL
not	NULL
sufficient	NULL
for	NULL
LPS-dependent	NULL
activity	NULL
(	NULL
in	NULL
particular	NULL
,	NULL
see	NULL
construct	NULL
9	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
deleted	NULL
sequence	NULL
in	NULL
construct	NULL
10	NULL
with	NULL
sequences	NULL
of	NULL
a	NULL
collection	NULL
of	NULL
known	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
revealed	NULL
a	NULL
close	NULL
match	NULL
(	NULL
12	NULL
of	NULL
14	NULL
bp	NULL
between	NULL
-2882	NULL
and	NULL
-2869	NULL
)	NULL
with	NULL
that	NULL
required	NULL
for	NULL
binding	NULL
of	NULL
factor	NULL
NF-IL6	NULL
,	NULL
a	NULL
key	NULL
component	NULL
in	NULL
IL-6	NULL
gene	NULL
transcription	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
either	NULL
NF-IL6	NULL
or	NULL
a	NULL
related	NULL
factor	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
prolIL-1fB	NULL
gene	NULL
transcription	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
P	NULL
;	NULL
Xho/HT	NULL
and	NULL
P	NULL
;	NULL
Xho/PT	NULL
promoter	NULL
CAT	NULL
constructs	NULL
which	NULL
possessed	NULL
internal	NULL
deletions	NULL
between	NULL
-2729	NULL
and	NULL
either	NULL
-1097	NULL
or	NULL
-131	NULL
appeared	NULL
to	NULL
be	NULL
only	NULL
partially	NULL
active	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
intact	NULL
P	NULL
;	NULL
,	NULL
T	NULL
construct	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
additional	NULL
sequences	NULL
between	NULL
-2729	NULL
and	NULL
-1097	NULL
may	NULL
be	NULL
necessary	NULL
to	NULL
support	NULL
transcription	NULL
from	NULL
the	NULL
proIL-18B	NULL
promoter	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
support	NULL
and	NULL
extend	NULL
those	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
by	NULL
defining	NULL
additional	NULL
sequence	NULL
between	NULL
-2894	NULL
and	NULL
-2729	NULL
(	NULL
regions	NULL
E	NULL
through	NULL
I	NULL
)	NULL
to	NULL
be	NULL
indispensable	NULL
for	NULL
maximal	NULL
LPS	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
prolL-1B	NULL
gene	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
deletion	NULL
studies	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
are	NULL
insufficient	NULL
to	NULL
address	NULL
the	NULL
importance	NULL
of	NULL
DNA-protein	NULL
binding	NULL
sites	NULL
which	NULL
either	NULL
are	NULL
located	NULL
between	NULL
-2987	NULL
and	NULL
-2894	NULL
or	NULL
span	NULL
across	NULL
the	NULL
construct	NULL
terminus	NULL
located	NULL
at	NULL
-2987	NULL
.	NULL

However	NULL
,	NULL
the	NULL
deletion	NULL
data	NULL
for	NULL
the	NULL
prolIL-1B	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
support	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
sequence	NULL
between	NULL
-2987	NULL
and	NULL
-2923	NULL
(	NULL
region	NULL
C	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3B	NULL
reveal	NULL
a	NULL
complex	NULL
collection	NULL
of	NULL
regions	NULL
required	NULL
for	NULL
LPS	NULL
induction	NULL
,	NULL
as	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Table	NULL
1	NULL
and	NULL
Fig	NULL
.	NULL

3	NULL
show	NULL
that	NULL
murine	NULL
RAW	NULL
264.7	NULL
cells	NULL
and	NULL
human	NULL
THP-1	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
fos	NULL
CAT	NULL
constructs	NULL
revealed	NULL
similar	NULL
,	NULL
but	NULL
not	NULL
identical	NULL
,	NULL
results	NULL
which	NULL
may	NULL
reflect	NULL
differences	NULL
between	NULL
the	NULL
two	NULL
systems	NULL
.	NULL

The	NULL
most	NULL
striking	NULL
difference	NULL
is	NULL
the	NULL
higher	NULL
activity	NULL
,	NULL
relative	NULL
to	NULL
P	NULL
;	NULL
Xho/fos	NULL
,	NULL
for	NULL
the	NULL
P	NULL
,	NULL
-2864/fos	NULL
construct	NULL
transfected	NULL
in	NULL
RAW	NULL
264.7	NULL
versus	NULL
THP-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
construct	NULL
5	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
it	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
the	NULL
uninduced	NULL
CAT	NULL
activity	NULL
for	NULL
this	NULL
construct	NULL
is	NULL
threefold	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
P	NULL
;	NULL
Xho/fos	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
increased	NULL
activity	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
removal	NULL
of	NULL
sequences	NULL
which	NULL
act	NULL
as	NULL
a	NULL
silencer	NULL
only	NULL
in	NULL
the	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

As	NULL
described	NULL
above	NULL
,	NULL
Table	NULL
1	NULL
demonstrates	NULL
that	NULL
the	NULL
P	NULL
;	NULL
Xho/fos	NULL
construct	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
generated	NULL
transcription	NULL
activity	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
construct	NULL
3M	NULL
-	NULL
XT	NULL
,	NULL
which	NULL
contains	NULL
sequences	NULL
between	NULL
-3757	NULL
and	NULL
+12	NULL
.	NULL

Table	NULL
1	NULL
also	NULL
shows	NULL
that	NULL
the	NULL
relative	NULL
induction	NULL
capacity	NULL
of	NULL
the	NULL
P	NULL
;	NULL
Xho/fos	NULL
CAT	NULL
construct	NULL
transfected	NULL
into	NULL
human	NULL
THP-1	NULL
monocyte	NULL
cells	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
transfected	NULL
murine	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
requirements	NULL
for	NULL
LPS-inducible	NULL
transcription	NULL
are	NULL
common	NULL
to	NULL
human	NULL
and	NULL
mouse	NULL
cells	NULL
,	NULL
reflecting	NULL
the	NULL
likely	NULL
involvement	NULL
of	NULL
similar	NULL
transcription	NULL
factors	NULL
.	NULL

One	NULL
major	NULL
difference	NULL
between	NULL
the	NULL
RAW	NULL
264.7	NULL
and	NULL
THP-1	NULL
cells	NULL
,	NULL
however	NULL
,	NULL
was	NULL
a	NULL
strong	NULL
suppression	NULL
of	NULL
activity	NULL
in	NULL
THP-1	NULL
associated	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
sequences	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
P	NULL
;	NULL
Xho	NULL
fragment	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
the	NULL
low	NULL
activity	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
for	NULL
3M	NULL
-	NULL
and	NULL
3M	NULL
-	NULL
P	NULL
;	NULL
,	NULL
Xho/PT	NULL
in	NULL
THP-1	NULL
cells	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
suppressive	NULL
sequences	NULL
suggests	NULL
the	NULL
possible	NULL
involvement	NULL
of	NULL
additional	NULL
positive-acting	NULL
factors	NULL
in	NULL
THP-1	NULL
cells	NULL
which	NULL
may	NULL
require	NULL
additional	NULL
sequences	NULL
that	NULL
lie	NULL
beyond	NULL
the	NULL
boundaries	NULL
of	NULL
the	NULL
P	NULL
,	NULL
T	NULL
DNA	NULL
.	NULL

Antisuppressive	NULL
factors	NULL
could	NULL
bind	NULL
to	NULL
such	NULL
sequences	NULL
and	NULL
overcome	NULL
the	NULL
suppression	NULL
in	NULL
the	NULL
intact	NULL
chro-mosomal	NULL
gene	NULL
.	NULL

Identification	NULL
of	NULL
protein	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
proIL-1B	NULL
LPS	NULL
response	NULL
element	NULL
.	NULL

EMSAs	NULL
were	NULL
used	NULL
to	NULL
examine	NULL
the	NULL
nature	NULL
of	NULL
specific	NULL
DNA-protein	NULL
binding	NULL
within	NULL
the	NULL
P	NULL
;	NULL
Xho	NULL
enhancer	NULL
.	NULL

Figure	NULL
4A	NULL
is	NULL
a	NULL
schematic	NULL
representation	NULL
of	NULL
regions	NULL
D	NULL
through	NULL
H	NULL
indicating	NULL
the	NULL
locations	NULL
of	NULL
gene	NULL
fragments	NULL
which	NULL
were	NULL
used	NULL
either	NULL
as	NULL
radiolabeled	NULL
EMSA	NULL
probes	NULL
or	NULL
as	NULL
specific	NULL
unlabeled	NULL
competitors	NULL
.	NULL

Figure	NULL
4B	NULL
shows	NULL
the	NULL
sequences	NULL
of	NULL
the	NULL
synthetic	NULL
double-stranded	NULL
oligonucleotides	NULL
which	NULL
were	NULL
used	NULL
for	NULL
EMSA	NULL
analysis	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
demonstrate	NULL
that	NULL
oligonucleotide	NULL
IL6/I	NULL
,	NULL
containing	NULL
the	NULL
NF-IL6-like	NULL
sequence	NULL
in	NULL
the	NULL
human	NULL
proIL-1f	NULL
gene	NULL
,	NULL
did	NULL
bind	NULL
a	NULL
THP-1	NULL
cell	NULL
nuclear	NULL
factor	NULL
which	NULL
was	NULL
effectively	NULL
competed	NULL
for	NULL
by	NULL
unlabeled	NULL
oligonucleotide	NULL
IL6	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
human	NULL
NF-IL6	NULL
binding	NULL
site	NULL
previously	NULL
characterized	NULL
by	NULL
Akira	NULL
et	NULL
al	NULL
.	NULL

(	NULL
2	NULL
)	NULL
(	NULL
compare	NULL
lanes	NULL
1	NULL
through	NULL
3	NULL
with	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

As	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
this	NULL
factor	NULL
generates	NULL
a	NULL
pattern	NULL
of	NULL
two	NULL
or	NULL
more	NULL
bands	NULL
,	NULL
similar	NULL
to	NULL
that	NULL
reported	NULL
for	NULL
the	NULL
various	NULL
forms	NULL
of	NULL
the	NULL
NF-IL6	NULL
(	NULL
C/EBP	NULL
)	NULL
factors	NULL
(	NULL
6	NULL
,	NULL
27	NULL
,	NULL
49	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
this	NULL
protein	NULL
was	NULL
also	NULL
specifically	NULL
competed	NULL
for	NULL
by	NULL
the	NULL
unlabeled	NULL
oligonucleotide	NULL
IL6/I	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
and	NULL
was	NULL
not	NULL
strongly	NULL
competed	NULL
for	NULL
by	NULL
mutated	NULL
versions	NULL
of	NULL
the	NULL
IL6/I	NULL
binding	NULL
sequence	NULL
(	NULL
AIL6/I	NULL
and	NULL
IL6/Im	NULL
;	NULL
lanes	NULL
8	NULL
through	NULL
11	NULL
)	NULL
.	NULL

Figure	NULL
5B	NULL
shows	NULL
that	NULL
the	NULL
two	NULL
distinct	NULL
mutated	NULL
radiolabeled	NULL
IL6/I	NULL
probes	NULL
did	NULL
not	NULL
bind	NULL
the	NULL
THP-1	NULL
NF-IL6-like	NULL
protein	NULL
as	NULL
well	NULL
as	NULL
they	NULL
bound	NULL
the	NULL
wild-type	NULL
sequence	NULL
found	NULL
in	NULL
the	NULL
prolL-1B	NULL
gene	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
AIL6/I	NULL
probe	NULL
appeared	NULL
to	NULL
bind	NULL
only	NULL
a	NULL
nonspecific	NULL
protein	NULL
which	NULL
could	NULL
not	NULL
be	NULL
displaced	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
NF-IL6	NULL
IS	NULL
IMPORTANT	NULL
FOR	NULL
prolL-18	NULL
GENE	NULL
EXPRESSION	NULL
1337	NULL
2780	NULL
A	NULL
2864	NULL
wr-ice|~283	NULL
``	NULL
)	NULL
|	NULL
ereiap-1	NULL
=	NULL
-2599	NULL
+298	NULL
2644	NULL
AP-1	NULL
I	NULL
c2923	NULL
NF-	NULL
«	NULL
B	NULL
1	NULL
+4	NULL
t	NULL
|	NULL
for	NULL
n	NULL
IT	NULL
t	NULL
NF-B2	NULL
AP-1	NULL
Xba	NULL
Pvull	NULL
Xhoul	NULL
NF-B1	NULL
(	NULL
21,729	NULL
)	NULL
Average	NULL
CAT	NULL
Activity	NULL
(	NULL
-3757	NULL
)	NULL
(	NULL
-3132	NULL
)	NULL
Styl	NULL
(	NULL
+2894	NULL
)	NULL
``	NULL
wan	NULL
\	NULL
(	NULL
2507	NULL
)	NULL
(	NULL
-2864	NULL
)	NULL
RAW264.7	NULL
Cells	NULL
THP-1	NULL
Cells	NULL
B	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
1	NULL
P	NULL
,	NULL
-2599	NULL
]	NULL
cat	NULL
]	NULL
1	NULL
1	NULL
2	NULL
_	NULL
P2	NULL
Xho	NULL
|	NULL
2	NULL
2	NULL
3	NULL
P	NULL
,	NULL
-2as1	NULL
}	NULL
———m	NULL
3	NULL
3	NULL
4	NULL
P2	NULL
2844	NULL
f	NULL
CAT	NULL
]	NULL
a	NULL
a	NULL
5	NULL
P	NULL
,	NULL
-2864	NULL
CAT	NULL
5	NULL
5	NULL
6	NULL
-	NULL
P2	NULL
Xhor	NULL
6	NULL
6	NULL
T	NULL
-2987	NULL
:	NULL
-2599	NULL
|	NULL
cat	NULL
)	NULL
7	NULL
7T	NULL
8	NULL
-2987	NULL
:	NULL
-2780	NULL
s	NULL
8	NULL
9	NULL
-2923	NULL
:	NULL
-2780	NULL
a	NULL
9	NULL
10	NULL
P2XhoaXm	NULL
P	NULL
MN	NULL
10	NULL
10	NULL
11	NULL
fos	NULL
CAT	NULL
Vector	NULL
~	NULL
MCAT	NULL
!	NULL

11	NULL
1	NULL
C	NULL
~2884	NULL
c2844	NULL
-2894	NULL
i	NULL
i-2831	NULL
-2987	NULL
-2023	NULL
}	NULL
1	NULL
l	NULL
}	NULL
-arso-2rze	NULL
|	NULL
-2500	NULL
-3757	NULL
-3132	NULL
'm-as	NULL
}	NULL
m	NULL
o	NULL
prolL-18	NULL
Promoter	NULL
(	NULL
from	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
fos	NULL
Promoter	NULL
(	NULL
from	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Functional	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
proIL-1B	NULL
far-upstream	NULL
LPS-responsive	NULL
region	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
map	NULL
of	NULL
the	NULL
sequence	NULL
located	NULL
between	NULL
-3757	NULL
and	NULL
-2599	NULL
.	NULL

Open	NULL
boxes	NULL
locate	NULL
sequence	NULL
motifs	NULL
suggesting	NULL
potential	NULL
protein	NULL
binding	NULL
sites	NULL
.	NULL

Closed	NULL
boxes	NULL
locate	NULL
experimentally	NULL
determined	NULL
protein	NULL
binding	NULL
sites	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Deletion	NULL
constructs	NULL
.	NULL

Deletion	NULL
studies	NULL
for	NULL
the	NULL
-3132	NULL
to	NULL
-2599	NULL
region	NULL
used	NULL
the	NULL
murine	NULL
c-fos	NULL
promoter	NULL
transfected	NULL
either	NULL
into	NULL
RAW	NULL
264.7	NULL
or	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
indicated	NULL
gene	NULL
sequences	NULL
were	NULL
inserted	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
-56	NULL
to	NULL
+109	NULL
region	NULL
of	NULL
the	NULL
murine	NULL
c-fos	NULL
promoter	NULL
(	NULL
stippled	NULL
box	NULL
)	NULL
in	NULL
the	NULL
fos	NULL
CAT	NULL
vector	NULL
.	NULL

This	NULL
region	NULL
consists	NULL
of	NULL
positions	NULL
-56	NULL
to	NULL
+109	NULL
of	NULL
the	NULL
murine	NULL
c-fos	NULL
genomic	NULL
DNA	NULL
sequence	NULL
and	NULL
appears	NULL
to	NULL
be	NULL
devoid	NULL
either	NULL
of	NULL
enhancer	NULL
activity	NULL
or	NULL
of	NULL
a	NULL
strong	NULL
relationship	NULL
to	NULL
sequence	NULL
motifs	NULL
for	NULL
a	NULL
large	NULL
collection	NULL
of	NULL
known	NULL
transcription	NULL
factors	NULL
(	NULL
2a	NULL
,	NULL
33	NULL
)	NULL
.	NULL

The	NULL
CAT	NULL
data	NULL
are	NULL
calculated	NULL
and	NULL
presented	NULL
as	NULL
for	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
value	NULL
for	NULL
each	NULL
construct	NULL
represents	NULL
results	NULL
from	NULL
a	NULL
minimum	NULL
of	NULL
two	NULL
experiments	NULL
(	NULL
average	NULL
was	NULL
five	NULL
experiments	NULL
)	NULL
with	NULL
average	NULL
deviations	NULL
of	NULL
29	NULL
%	NULL
for	NULL
the	NULL
data	NULL
from	NULL
RAW	NULL
264.7	NULL
cells	NULL
and	NULL
52	NULL
%	NULL
for	NULL
the	NULL
data	NULL
from	NULL
THP-1	NULL
cells	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Summary	NULL
of	NULL
the	NULL
murine	NULL
RAW	NULL
264.7	NULL
cell	NULL
CAT	NULL
data	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
panels	NULL
A	NULL
and	NULL
B.	NULL
Shaded	NULL
regions	NULL
correspond	NULL
to	NULL
those	NULL
that	NULL
are	NULL
required	NULL
(	NULL
solid	NULL
)	NULL
,	NULL
strongly	NULL
supportive	NULL
(	NULL
cross-hatched	NULL
)	NULL
,	NULL
weakly	NULL
supportive	NULL
(	NULL
stippled	NULL
)	NULL
,	NULL
and	NULL
not	NULL
determined	NULL
or	NULL
unimportant	NULL
(	NULL
open	NULL
)	NULL
.	NULL

These	NULL
regions	NULL
are	NULL
designated	NULL
A	NULL
through	NULL
J	NULL
and	NULL
are	NULL
described	NULL
in	NULL
detail	NULL
throughout	NULL
the	NULL
text	NULL
.	NULL

Bold	NULL
brackets	NULL
locate	NULL
compensatory	NULL
regions	NULL
which	NULL
appear	NULL
to	NULL
be	NULL
able	NULL
to	NULL
substitute	NULL
for	NULL
one	NULL
another	NULL
.	NULL

The	NULL
open	NULL
bracket	NULL
locates	NULL
the	NULL
PMA-responsive	NULL
region	NULL
previously	NULL
reported	NULL
(	NULL
5	NULL
)	NULL
.	NULL

by	NULL
unlabeled	NULL
IL6/I	NULL
competitor	NULL
(	NULL
compare	NULL
lane	NULL
6	NULL
with	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
IL6/Im	NULL
probe	NULL
bound	NULL
a	NULL
specific	NULL
NF-IL6-like	NULL
displaceable	NULL
factor	NULL
(	NULL
lanes	NULL
14	NULL
and	NULL
15	NULL
)	NULL
but	NULL
did	NULL
not	NULL
form	NULL
all	NULL
of	NULL
the	NULL
NF-IL6-like	NULL
complexes	NULL
observed	NULL
with	NULL
the	NULL
IL6/I	NULL
probe	NULL
(	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
12	NULL
)	NULL
.	NULL

This	NULL
result	NULL
indicated	NULL
that	NULL
the	NULL
sequence	NULL
alteration	NULL
did	NULL
not	NULL
completely	NULL
abrogate	NULL
binding	NULL
(	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

It	NULL
therefore	NULL
appeared	NULL
that	NULL
NF-IL6	NULL
,	NULL
or	NULL
another	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
protein	NULL
family	NULL
,	NULL
binds	NULL
to	NULL
an	NULL
essential	NULL
LPS-responsive	NULL
region	NULL
of	NULL
the	NULL
human	NULL
proIL-1f	NULL
gene	NULL
.	NULL

A	NULL
counterpart	NULL
to	NULL
the	NULL
THP-1	NULL
cell	NULL
NF-IL6-like	NULL
factor	NULL
appeared	NULL
to	NULL
also	NULL
exist	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
THP-1	NULL
cells	NULL
,	NULL
RAW	NULL
264.7	NULL
cells	NULL
did	NULL
not	NULL
generate	NULL
high-quality	NULL
EMSA	NULL
data	NULL
but	NULL
rather	NULL
yielded	NULL
band	NULL
patterns	NULL
which	NULL
,	NULL
although	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
THP-1	NULL
ex-tracts	NULL
,	NULL
were	NULL
more	NULL
diffuse	NULL
.	NULL

Figure	NULL
6A	NULL
shows	NULL
EMSA	NULL
analysis	NULL
of	NULL
the	NULL
region	NULL
immediately	NULL
downstream	NULL
of	NULL
the	NULL
NF-IL6-like	NULL
binding	NULL
site	NULL
,	NULL
using	NULL
an	NULL
84-bp	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
probe	NULL
M1	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Two	NULL
primary	NULL
groups	NULL
of	NULL
bands	NULL
,	NULL
labeled	NULL
NF-B1	NULL
and	NULL
NF-B2	NULL
,	NULL
ap-	NULL
peared	NULL
to	NULL
define	NULL
the	NULL
binding	NULL
of	NULL
two	NULL
protein	NULL
classes	NULL
.	NULL

The	NULL
competitor	NULL
oligonucleotides	NULL
MSS	NULL
and	NULL
23D	NULL
appeared	NULL
to	NULL
displace	NULL
both	NULL
the	NULL
NF-B1	NULL
and	NULL
NF-B2	NULL
band	NULL
groups	NULL
,	NULL
whereas	NULL
oligonucleotides	NULL
D8	NULL
,	NULL
B1	NULL
,	NULL
and	NULL
B2	NULL
selectively	NULL
displaced	NULL
only	NULL
one	NULL
group	NULL
or	NULL
the	NULL
other	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
data	NULL
,	NULL
it	NULL
appears	NULL
as	NULL
though	NULL
at	NULL
least	NULL
two	NULL
proteins	NULL
bind	NULL
to	NULL
the	NULL
two	NULL
adjacent	NULL
sites	NULL
on	NULL
the	NULL
M1	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Attempts	NULL
to	NULL
footprint	NULL
these	NULL
two	NULL
binding	NULL
sites	NULL
on	NULL
oligonucleotide	NULL
M1	NULL
by	NULL
using	NULL
methylation	NULL
interference	NULL
have	NULL
generated	NULL
very	NULL
weak	NULL
results	NULL
,	NULL
probably	NULL
because	NULL
of	NULL
the	NULL
complex	NULL
band	NULL
patterns	NULL
for	NULL
the	NULL
two	NULL
groups	NULL
of	NULL
bands	NULL
.	NULL

Nonetheless	NULL
,	NULL
the	NULL
methylation	NULL
interference	NULL
data	NULL
suggested	NULL
the	NULL
possibility	NULL
that	NULL
sites	NULL
B1	NULL
and	NULL
B2	NULL
overlap	NULL
at	NULL
positions	NULL
-2845	NULL
and	NULL
-2844	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
have	NULL
allowed	NULL
us	NULL
to	NULL
design	NULL
mutant	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
which	NULL
decreased	NULL
the	NULL
binding	NULL
of	NULL
these	NULL
factors	NULL
.	NULL

Figure	NULL
6A	NULL
,	NULL
lanes	NULL
12	NULL
and	NULL
13	NULL
as	NULL
well	NULL
as	NULL
lanes	NULL
17	NULL
and	NULL
18	NULL
,	NULL
reveal	NULL
that	NULL
two	NULL
such	NULL
mutants	NULL
(	NULL
B1m	NULL
and	NULL
B2m	NULL
)	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
wild-type	NULL
sequences	NULL
(	NULL
B1	NULL
in	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
;	NULL
B2	NULL
in	NULL
lanes	NULL
15	NULL
and	NULL
16	NULL
)	NULL
,	NULL
were	NULL
not	NULL
efficient	NULL
competitors	NULL
for	NULL
the	NULL
NF-B1	NULL
and	NULL
NF-B2	NULL
factors	NULL
.	NULL

The	NULL
locations	NULL
1338	NULL
SHIRAKAWA	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
puss	NULL
(	NULL
Hind11	NULL
)	NULL
(	NULL
Ddet	NULL
)	NULL
(	NULL
Sail	NULL
)	NULL
-2923	NULL
+2844	NULL
-2780	NULL
-2907	NULL
-2864	NULL
-2831	NULL
(	NULL
Styl	NULL
)	NULL
(	NULL
Mail	NULL
)	NULL
(	NULL
Sait	NULL
)	NULL
NFIL	NULL
&	NULL
/	NULL
NFiLG	NULL
,	NULL
Bl	NULL
$	NULL
2	NULL
M1	NULL
pe	NULL
+2862	NULL
-2840	NULL
pee	NULL
-2850	NULL
-2831	NULL
-158	NULL
145	NULL
B	NULL
agettgctcgagCGTCACATTGCACAATCTTAATAAG	NULL
IL6	NULL
acgagctcGCAGTGTAACGTGTTAGAATTATTCAGCT	NULL
AIL6/I	NULL
IL6/I	NULL
CTTGGGAAGACAGGATCTGATACATACGTTECACAACCTATTT	NULL
CCTTCTETCCTAGACTATGTATECAACGTGTTGGATAAA	NULL
+2882	NULL
+2869	NULL
-2882	NULL
-2869	NULL
CAGEATCTGATACATACGeTGaACACCCTATTTGAC	NULL
GACTATGTATGCgACtTETgGGATAAACTG	NULL
®	NULL
IL6/Im	NULL
-2855	NULL
2844	NULL
1	NULL
agctCATAAGAGGTTTCACTTCCTGAGgec	NULL
B	NULL
GTATTCTCCAAAGTGAAGGACTCeqgaget	NULL
somme	NULL
2855	NULL
+2844	NULL
Bim	NULL
CATAAGAttTTTaAaTTaaTGAGATGGATGGGATGGT	NULL
TTGGATAAACTGTATTCTaqAAAtTtAAttACTCTAC	NULL
os	NULL
a	NULL
o	NULL
ee	NULL
-2842	NULL
.	NULL

-2836	NULL
B2	NULL
CACTTCCTGAGATGGATGGGc	NULL
GTGAAGGACTCTACCTACCCgggeccagetg99	NULL
+2842	NULL
2836	NULL
CACTTCCTaAtAT	NULL
taATGGGATGGTAGCAGATT	NULL
ATTCTCCAAAGTGAAGGAtTaTAatTACCCT	NULL
B2m	NULL
-2945	NULL
+2922	NULL
I	NULL
B3	NULL
ageTGGGGATCGGAAGGAAGTGCTGTG	NULL
CCCCTAGCCTTCCTTCACGACACaget	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Gene	NULL
fragments	NULL
and	NULL
oligonucleotides	NULL
used	NULL
for	NULL
EMSAs	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
map	NULL
showing	NULL
the	NULL
location	NULL
relative	NULL
to	NULL
the	NULL
proIL-1fB	NULL
gene	NULL
sequence	NULL
for	NULL
various	NULL
fragments	NULL
used	NULL
either	NULL
as	NULL
EMSA	NULL
probes	NULL
or	NULL
as	NULL
competitors	NULL
(	NULL
see	NULL
text	NULL
for	NULL
details	NULL
)	NULL
.	NULL

Open	NULL
ovals	NULL
locate	NULL
factor	NULL
binding	NULL
sites	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Sequences	NULL
for	NULL
synthetic	NULL
double-stranded	NULL
oligonucleotides	NULL
used	NULL
as	NULL
EMSA	NULL
probes	NULL
or	NULL
competitors	NULL
.	NULL

Uppercase	NULL
letters	NULL
denote	NULL
native	NULL
proIL-1B	NULL
sequence	NULL
,	NULL
whereas	NULL
lowercase	NULL
letters	NULL
represent	NULL
nucleotides	NULL
not	NULL
found	NULL
in	NULL
The	NULL
IL6	NULL
probe	NULL
contains	NULL
the	NULL
human	NULL
IL-6	NULL
gene	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
NF-IL6	NULL
Mor	NULL
.	NULL

CELr	NULL
.	NULL

Broc	NULL
.	NULL

of	NULL
the	NULL
base	NULL
changes	NULL
in	NULL
the	NULL
two	NULL
mutant	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
define	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
these	NULL
two	NULL
factors	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
good	NULL
agreement	NULL
with	NULL
our	NULL
tentative	NULL
footprint	NULL
data	NULL
,	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
NF-B1	NULL
and	NULL
NF-B2	NULL
appear	NULL
to	NULL
be	NULL
separated	NULL
by	NULL
no	NULL
more	NULL
than	NULL
a	NULL
single	NULL
base	NULL
pair	NULL
.	NULL

To	NULL
more	NULL
carefully	NULL
examine	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
NF-B1	NULL
and	NULL
NF-B2	NULL
binding	NULL
sites	NULL
,	NULL
the	NULL
B1	NULL
and	NULL
B2	NULL
oligonucleotides	NULL
used	NULL
as	NULL
unlabeled	NULL
competitors	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
were	NULL
employed	NULL
as	NULL
radiolabeled	NULL
EMSA	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

These	NULL
data	NULL
,	NULL
which	NULL
were	NULL
derived	NULL
by	NULL
using	NULL
probes	NULL
substantially	NULL
shorter	NULL
than	NULL
the	NULL
M1	NULL
oligonucleotide	NULL
used	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
suggested	NULL
some	NULL
interesting	NULL
contrasts	NULL
.	NULL

First	NULL
,	NULL
the	NULL
overall	NULL
binding	NULL
complexity	NULL
was	NULL
reduced	NULL
for	NULL
both	NULL
factors	NULL
,	NULL
and	NULL
in	NULL
particular	NULL
,	NULL
the	NULL
NF-B2	NULL
factor	NULL
appeared	NULL
to	NULL
be	NULL
represented	NULL
as	NULL
a	NULL
single	NULL
specific	NULL
band	NULL
rather	NULL
than	NULL
three	NULL
bands	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
factor	NULL
NF-B1	NULL
appeared	NULL
to	NULL
be	NULL
compromised	NULL
by	NULL
the	NULL
use	NULL
of	NULL
the	NULL
shorter	NULL
B1	NULL
oligonucleotide	NULL
,	NULL
suggesting	NULL
a	NULL
requirement	NULL
either	NULL
for	NULL
additional	NULL
DNA	NULL
sequence	NULL
or	NULL
,	NULL
perhaps	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
NF-B2	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

Mutant	NULL
protein	NULL
binding	NULL
sites	NULL
in	NULL
P	NULL
,	NULL
Xho/fos	NULL
CAT	NULL
decrease	NULL
LPS-specific	NULL
enhancer	NULL
activity	NULL
.	NULL

To	NULL
ascertain	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
specific	NULL
protein-DNA	NULL
associations	NULL
,	NULL
the	NULL
above-described	NULL
mutations	NULL
were	NULL
examined	NULL
for	NULL
functional	NULL
relevance	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
LPS-responsive	NULL
P	NULL
;	NULL
Xho/fos	NULL
CAT	NULL
construct	NULL
.	NULL

Four	NULL
distinct	NULL
mutants	NULL
were	NULL
derived	NULL
from	NULL
overlapping	NULL
PCR	NULL
primer	NULL
techniques	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
mutants	NULL
contained	NULL
a	NULL
single	NULL
mutated	NULL
binding	NULL
site	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
ILé/Im	NULL
,	NULL
AIL6/I	NULL
,	NULL
Blm	NULL
,	NULL
and	NULL
BZ2m	NULL
)	NULL
which	NULL
contained	NULL
either	NULL
multiple	NULL
base	NULL
substitutions	NULL
or	NULL
a	NULL
deletion	NULL
in	NULL
P	NULL
;	NULL
Xho/fos	NULL
CAT	NULL
.	NULL

The	NULL
resulting	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
RAW	NULL
264.7	NULL
cells	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
as	NULL
shown	NULL
in	NULL
Table	NULL
2	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
the	NULL
NF-IL6	NULL
and	NULL
NF-B1	NULL
binding	NULL
sites	NULL
were	NULL
important	NULL
for	NULL
LPS-induced	NULL
gene	NULL
transcription	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
B2	NULL
site	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
required	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Table	NULL
2	NULL
shows	NULL
that	NULL
the	NULL
IL-6	NULL
site	NULL
is	NULL
also	NULL
important	NULL
for	NULL
expression	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

Since	NULL
the	NULL
14-bp	NULL
deletion	NULL
in	NULL
P	NULL
;	NULL
XhoAILO6/I	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
and	NULL
the	NULL
longer	NULL
31-bp	NULL
deletion	NULL
in	NULL
P	NULL
,	NULL
XhoAXM	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
construct	NULL
10	NULL
)	NULL
generated	NULL
similar	NULL
LPS-induced	NULL
CAT	NULL
activities	NULL
relative	NULL
to	NULL
the	NULL
P	NULL
;	NULL
,	NULL
CAT	NULL
construct	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
loss	NULL
of	NULL
the	NULL
IL-6	NULL
site	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
reduced	NULL
activity	NULL
of	NULL
P	NULL
,	NULL
;	NULL
XhoAXM	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
human	NULL
prolL-16B	NULL
gene	NULL
by	NULL
PMA	NULL
and	NULL
mature	NULL
IL-1B	NULL
protein	NULL
.	NULL

The	NULL
LPS	NULL
induction	NULL
of	NULL
IL-1	NULL
provides	NULL
a	NULL
useful	NULL
model	NULL
system	NULL
for	NULL
monocyte	NULL
activation	NULL
,	NULL
which	NULL
has	NULL
been	NULL
extensively	NULL
investigated	NULL
(	NULL
13	NULL
)	NULL
.	NULL

However	NULL
,	NULL
other	NULL
agents	NULL
such	NULL
as	NULL
PMA	NULL
and	NULL
mature	NULL
IL-1	NULL
proteins	NULL
have	NULL
also	NULL
been	NULL
reported	NULL
to	NULL
induce	NULL
prolIlL-1B	NULL
gene	NULL
transcription	NULL
(	NULL
9	NULL
,	NULL
16	NULL
)	NULL
.	NULL

The	NULL
PMA	NULL
stimulus	NULL
is	NULL
especially	NULL
relevant	NULL
because	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
expression	NULL
via	NULL
a	NULL
distinct	NULL
pathway	NULL
(	NULL
16	NULL
,	NULL
42	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
potential	NULL
for	NULL
autocrine	NULL
effect	NULL
renders	NULL
the	NULL
action	NULL
of	NULL
mature	NULL
IL-1B	NULL
on	NULL
its	NULL
own	NULL
gene	NULL
of	NULL
interest	NULL
as	NULL
well	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
primary	NULL
human	NULL
dermal	NULL
fibroblasts	NULL
with	NULL
con	NULL
factor	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
2	NULL
)	NULL
,	NULL
whereas	NULL
IL6/I	NULL
contains	NULL
the	NULL
human	NULL
proIL-18	NULL
NF-IL6-like	NULL
sequence	NULL
.	NULL

The	NULL
AILO/I	NULL
designation	NULL
indicates	NULL
the	NULL
region	NULL
deleted	NULL
in	NULL
the	NULL
AIL6/I	NULL
deletion	NULL
oligonucleotide	NULL
.	NULL

Bracketed	NULL
regions	NULL
above	NULL
sequences	NULL
signify	NULL
specific	NULL
protein	NULL
binding	NULL
and	NULL
recognition	NULL
sites	NULL
defined	NULL
by	NULL
the	NULL
location	NULL
of	NULL
mutated	NULL
nucleotides	NULL
which	NULL
affect	NULL
factor	NULL
binding	NULL
.	NULL

The	NULL
bold	NULL
bar	NULL
beneath	NULL
the	NULL
B1	NULL
oligonucleotide	NULL
sequence	NULL
denotes	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
beta	NULL
interferon	NULL
IRF-1	NULL
hexamer	NULL
motif	NULL
.	NULL

Bullets	NULL
indicate	NULL
the	NULL
sites	NULL
of	NULL
specific	NULL
mutations	NULL
designed	NULL
to	NULL
abrogate	NULL
protein	NULL
binding	NULL
.	NULL

Nucleotide	NULL
substitutions	NULL
in	NULL
the	NULL
IL6/Im	NULL
probe	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
studies	NULL
of	NULL
Akira	NULL
et	NULL
al	NULL
.	NULL

(	NULL
2	NULL
)	NULL
.	NULL

Substitutions	NULL
in	NULL
the	NULL
Bim	NULL
and	NULL
B2m	NULL
probes	NULL
were	NULL
derived	NULL
from	NULL
preliminary	NULL
methylation	NULL
interference	NULL
analysis	NULL
results	NULL
(	NULL
see	NULL
text	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
A	NULL
P	NULL
a	NULL
&	NULL
~	NULL
&	NULL
B	NULL
Lok	NULL
x	NULL
o	NULL
x	NULL
o	NULL
T	NULL
a	NULL
a	NULL
o	NULL
0	NULL
o	NULL
o	NULL
2	NULL
g	NULL
f	NULL
g	NULL
$	NULL
c	NULL
c	NULL
£	NULL
c	NULL
3	NULL
g	NULL
£	NULL
c	NULL
&	NULL
5	NULL
&	NULL
C	NULL
€	NULL
c	NULL
-	NULL
<	NULL
s	NULL
4	NULL
>	NULL
.s	NULL
§	NULL
$	NULL
&	NULL
.	NULL

%	NULL
5	NULL
an	NULL
«	NULL
s	NULL
2	NULL
J	NULL
6	NULL
-o	NULL
Competitor	NULL
:	NULL
&	NULL
om	NULL
a	NULL
Ido	NULL
g	NULL
dg	NULL
f	NULL
s	NULL
<	NULL
g	NULL
g	NULL
1	NULL
2	NULL
:	NULL
2	NULL
4	NULL
5	NULL
6	NULL
``	NULL
0	NULL
_9	NULL
10	NULL
.	NULL

11	NULL
NF-IL6	NULL
&	NULL
'~	NULL
,	NULL
NF-IL6	NULL
NF-IL6	NULL
IS	NULL
IMPORTANT	NULL
FOR	NULL
proIL-1B	NULL
GENE	NULL
EXPRESSION	NULL
1339	NULL
IL6/1	NULL
-	NULL
Probe	NULL
AIL6/1	NULL
Probe	NULL
IL6/Im	NULL
-	NULL
Probe	NULL
M	NULL
1	NULL
T	NULL
1	NULL
&	NULL
z	NULL
&	NULL
a	NULL
%	NULL
a	NULL
<	NULL
8	NULL
B	NULL
a	NULL
£	NULL
§	NULL
20k	NULL
e	NULL
25-4	NULL
§	NULL
C	NULL
g	NULL
§	NULL
8	NULL
C	NULL
&	NULL
Z	NULL
5	NULL
*2	NULL
&	NULL
o	NULL
o	NULL
o	NULL
&	NULL
§	NULL
£	NULL
£	NULL
C	NULL
y	NULL
£	NULL
©	NULL
$	NULL
87	NULL
EA	NULL
c=	NULL
~	NULL
E	NULL
=o	NULL
oz	NULL
$	NULL
=	NULL
z	NULL
5	NULL
n	NULL
nog	NULL
s	NULL
[	NULL
g	NULL
s	NULL
n	NULL
2	NULL
3	NULL
$	NULL
a	NULL
s	NULL
2	NULL
3	NULL
Competitor	NULL
:	NULL
Z	NULL
®	NULL
A	NULL
=	NULL
-	NULL
A	NULL
2	NULL
oz	NULL
303	NULL
1	NULL
2	NULL
4	NULL
5-6	NULL
[	NULL
T	NULL
§	NULL
§	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Binding	NULL
of	NULL
an	NULL
NF-IL6-like	NULL
protein	NULL
to	NULL
the	NULL
proIL-1B	NULL
gene	NULL
.	NULL

All	NULL
lanes	NULL
contained	NULL
nuclear	NULL
extract	NULL
derived	NULL
from	NULL
THP-1	NULL
cells	NULL
treated	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
pg/ml	NULL
!	NULL
)	NULL

for	NULL
45	NULL
min	NULL
.	NULL

Unlabeled	NULL
competitors	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
were	NULL
used	NULL
in	NULL
molar	NULL
excess	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
figures	NULL
within	NULL
parentheses	NULL
.	NULL

The	NULL
cold	NULL
competitor	NULL
labeled	NULL
as	NULL
B3	NULL
corresponds	NULL
to	NULL
DNA	NULL
sequence	NULL
located	NULL
between	NULL
-2945	NULL
and	NULL
-2922	NULL
,	NULL
which	NULL
appears	NULL
to	NULL
be	NULL
unrelated	NULL
to	NULL
either	NULL
the	NULL
NF-B1	NULL
or	NULL
NF-B2	NULL
sequence	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
using	NULL
radiolabeled	NULL
probe	NULL
IL6/I	NULL
;	NULL
(	NULL
B	NULL
)	NULL
EMSA	NULL
using	NULL
radiolabeled	NULL
probes	NULL
and	NULL
unlabeled	NULL
competitors	NULL
as	NULL
indicated	NULL
and	NULL
LPS-treated	NULL
THP-1	NULL
nuclear	NULL
extracts	NULL
.	NULL

structs	NULL
3M	NULL
-	NULL
P	NULL
;	NULL
T	NULL
and	NULL
3M	NULL
-	NULL
XT	NULL
was	NULL
inducible	NULL
with	NULL
recombinant	NULL
human	NULL
IL-1B	NULL
protein	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
IL-1B	NULL
protein	NULL
induction	NULL
of	NULL
3M	NULL
-	NULL
XT	NULL
appeared	NULL
to	NULL
respond	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
.	NULL

Similarly	NULL
,	NULL
Table	NULL
3	NULL
also	NULL
shows	NULL
that	NULL
transfection	NULL
of	NULL
both	NULL
RAW	NULL
264.7	NULL
monocytes	NULL
and	NULL
HeLa	NULL
cells	NULL
with	NULL
the	NULL
P	NULL
;	NULL
Xho/fos	NULL
construct	NULL
was	NULL
sensitive	NULL
to	NULL
PMA	NULL
as	NULL
a	NULL
stimulus	NULL
.	NULL

Consequently	NULL
,	NULL
the	NULL
P	NULL
;	NULL
Xho	NULL
region	NULL
of	NULL
the	NULL
proIL-1f	NULL
gene	NULL
appears	NULL
to	NULL
respond	NULL
to	NULL
at	NULL
least	NULL
two	NULL
distinct	NULL
induction	NULL
signals	NULL
,	NULL
namely	NULL
,	NULL
LPS	NULL
and	NULL
PMA	NULL
,	NULL
and	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
response	NULL
to	NULL
mature	NULL
IL-1B	NULL
protein	NULL
as	NULL
well	NULL
.	NULL

Cell	NULL
type	NULL
transcription	NULL
specificity	NULL
requires	NULL
sequences	NULL
close	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Since	NULL
normal	NULL
cellular	NULL
expression	NULL
of	NULL
the	NULL
proIL-1B	NULL
gene	NULL
is	NULL
tissue	NULL
specific	NULL
,	NULL
in	NULL
that	NULL
only	NULL
certain	NULL
cell	NULL
types	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
monocytes	NULL
,	NULL
fibroblasts	NULL
,	NULL
endothelial	NULL
cells	NULL
,	NULL
and	NULL
smooth	NULL
muscle	NULL
cells	NULL
)	NULL
are	NULL
induction	NULL
competent	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
other	NULL
differentiation	NULL
or	NULL
activation	NULL
signals	NULL
such	NULL
as	NULL
viral	NULL
infection	NULL
,	NULL
it	NULL
is	NULL
of	NULL
interest	NULL
to	NULL
address	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
there	NULL
might	NULL
be	NULL
a	NULL
region	NULL
or	NULL
regions	NULL
essential	NULL
for	NULL
tissue-specific	NULL
expression	NULL
.	NULL

We	NULL
chose	NULL
to	NULL
use	NULL
HeLa	NULL
cells	NULL
,	NULL
which	NULL
we	NULL
had	NULL
previously	NULL
determined	NULL
were	NULL
refractory	NULL
to	NULL
proIL-1B	NULL
induction	NULL
by	NULL
PMA	NULL
(	NULL
8	NULL
)	NULL
,	NULL
for	NULL
transfection	NULL
studies	NULL
aimed	NULL
at	NULL
examining	NULL
cell	NULL
specificity	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Table	NULL
3	NULL
,	NULL
the	NULL
P	NULL
,	NULL
;	NULL
Xho/HT	NULL
construct	NULL
containing	NULL
the	NULL
proIL-1B	NULL
promoter	NULL
was	NULL
37-fold	NULL
less	NULL
efficiently	NULL
transcribed	NULL
in	NULL
uninduced	NULL
HeLa	NULL
than	NULL
was	NULL
the	NULL
P	NULL
;	NULL
Xho/fos	NULL
construct	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
P	NULL
;	NULL
Xho/	NULL
fos	NULL
is	NULL
PMA	NULL
inducible	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
but	NULL
P	NULL
;	NULL
Xho/HT	NULL
is	NULL
not	NULL
.	NULL

Examining	NULL
these	NULL
efficiency	NULL
differences	NULL
further	NULL
,	NULL
we	NULL
found	NULL
that	NULL
P	NULL
;	NULL
Xho/HT	NULL
was	NULL
also	NULL
eightfold	NULL
more	NULL
efficiently	NULL
expressed	NULL
in	NULL
LPS-treated	NULL
murine	NULL
RAW	NULL
cells	NULL
than	NULL
in	NULL
PMA-stimulated	NULL
HeLa	NULL
cells	NULL
(	NULL
Table	NULL
4	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
contrasted	NULL
with	NULL
results	NULL
for	NULL
the	NULL
P	NULL
;	NULL
Xho/fos	NULL
construct	NULL
,	NULL
which	NULL
was	NULL
efficiently	NULL
induced	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
.	NULL

To	NULL
further	NULL
examine	NULL
this	NULL
phenomenon	NULL
,	NULL
the	NULL
prolIL-1B	NULL
promoter	NULL
sequences	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
promoterless	NULL
3ME	NULL
vector	NULL
,	NULL
which	NULL
contains	NULL
one	NULL
complete	NULL
copy	NULL
of	NULL
the	NULL
232-bp	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
enhancer	NULL
.	NULL

Table	NULL
4	NULL
reveals	NULL
that	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
SV40	NULL
enhancer	NULL
,	NULL
which	NULL
is	NULL
generally	NULL
not	NULL
tissue	NULL
specific	NULL
(	NULL
39	NULL
)	NULL
,	NULL
the	NULL
proIL-1B	NULL
promoter	NULL
(	NULL
construct	NULL
3ME	NULL
-	NULL
HT	NULL
)	NULL
appeared	NULL
to	NULL
be	NULL
almost	NULL
30-fold	NULL
more	NULL
efficient	NULL
at	NULL
supporting	NULL
induced	NULL
transcription	NULL
in	NULL
RAW	NULL
monocytes	NULL
than	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
pSV2CAT	NULL
,	NULL
in	NULL
which	NULL
the	NULL
SV40	NULL
enhancer	NULL
was	NULL
used	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
,	NULL
was	NULL
more	NULL
highly	NULL
induced	NULL
in	NULL
HeLa	NULL
than	NULL
in	NULL
RAW	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
while	NULL
pSV2CAT	NULL
was	NULL
almost	NULL
3-fold	NULL
more	NULL
highly	NULL
expressed	NULL
than	NULL
3ME	NULL
-	NULL
HT	NULL
in	NULL
RAW	NULL
cells	NULL
,	NULL
in	NULL
HeLa	NULL
cells	NULL
the	NULL
difference	NULL
was	NULL
more	NULL
than	NULL
200-fold	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
proIL-1B	NULL
gene	NULL
tissue	NULL
specificity	NULL
appears	NULL
to	NULL
be	NULL
dependent	NULL
upon	NULL
sequences	NULL
close	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
and	NULL
independent	NULL
of	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
sequences	NULL
within	NULL
the	NULL
human	NULL
prolL-18	NULL
gene	NULL
which	NULL
are	NULL
essential	NULL
for	NULL
the	NULL
induction	NULL
and	NULL
maintenance	NULL
of	NULL
transcription	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
murine	NULL
RAW	NULL
264.7	NULL
cells	NULL
by	NULL
using	NULL
a	NULL
CAT	NULL
gene	NULL
reporter	NULL
demonstrates	NULL
that	NULL
far-upstream	NULL
sequences	NULL
located	NULL
between	NULL
-3132	NULL
and	NULL
-2729	NULL
(	NULL
P	NULL
;	NULL
Xho	NULL
fragment	NULL
)	NULL
are	NULL
important	NULL
for	NULL
the	NULL
induction	NULL
response	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
CAT	NULL
activity	NULL
,	NULL
a	NULL
minimum	NULL
of	NULL
two	NULL
subregions	NULL
(	NULL
labeled	NULL
C	NULL
and	NULL
E	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
contained	NULL
within	NULL
the	NULL
P	NULL
;	NULL
Xho	NULL
fragment	NULL
are	NULL
essential	NULL
for	NULL
activity	NULL
.	NULL

These	NULL
two	NULL
subregions	NULL
appear	NULL
to	NULL
be	NULL
required	NULL
for	NULL
activity	NULL
and	NULL
cooperate	NULL
with	NULL
adjacent	NULL
upstream	NULL
sequences	NULL
in	NULL
regions	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bror	NULL
.	NULL

SHIRAKAWA	NULL
ET	NULL
AL	NULL
.	NULL

1340	NULL
(	NULL
xool	NULL
)	NULL
wzg	NULL
(	NULL
xos	NULL
)	NULL
wzg	NULL
(	NULL
xoor	NULL
)	NULL
zg	NULL
(	NULL
xos	NULL
)	NULL
zg	NULL
auon	NULL
(	NULL
xool	NULL
)	NULL
wig	NULL
(	NULL
xos	NULL
)	NULL
wig	NULL
(	NULL
xoor	NULL
)	NULL
1g	NULL
(	NULL
xos	NULL
)	NULL
1g	NULL
(	NULL
xoor	NULL
)	NULL
sa	NULL
(	NULL
xos	NULL
)	NULL
sa	NULL
(	NULL
xoor	NULL
)	NULL
ag	NULL
:	NULL
(	NULL
xos	NULL
)	NULL
ag	NULL
:	NULL
(	NULL
xool	NULL
)	NULL
ss	NULL
(	NULL
xos	NULL
)	NULL
ssw	NULL
(	NULL
xoor	NULL
)	NULL
ond	NULL
ins-in/y	NULL
(	NULL
xos	NULL
)	NULL
ond	NULL
ins-in/y	NULL
@	NULL
uon	NULL
Competitor	NULL
:	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
7	NULL
6	NULL
(	NULL
xool	NULL
)	NULL
wuzg	NULL
(	NULL
xos	NULL
)	NULL
wzg	NULL
(	NULL
xoor	NULL
)	NULL
zg	NULL
(	NULL
xos	NULL
)	NULL
zd	NULL
(	NULL
xoor	NULL
)	NULL
wig	NULL
(	NULL
xos	NULL
)	NULL
wig	NULL
(	NULL
xoor	NULL
)	NULL
1g	NULL
(	NULL
xos	NULL
)	NULL
1d	NULL
(	NULL
xool	NULL
)	NULL
sg	NULL
Competitor	NULL
:	NULL
(	NULL
xoor	NULL
)	NULL
wzgd	NULL
(	NULL
xos	NULL
)	NULL
wz	NULL
(	NULL
xoor	NULL
)	NULL
zg	NULL
(	NULL
xos	NULL
)	NULL
zg	NULL
(	NULL
xool	NULL
)	NULL
wig	NULL
(	NULL
xos	NULL
)	NULL
wig	NULL
(	NULL
xoor	NULL
)	NULL
1g	NULL
(	NULL
xos	NULL
)	NULL
1d	NULL
(	NULL
xool	NULL
)	NULL
sg	NULL
(	NULL
xos	NULL
)	NULL
sg	NULL
quon	NULL
Competitor	NULL
:	NULL
$	NULL
10	NULL
11	NULL
8	NULL
9	NULL
10	NULL
11	NULL
8	NULL
e	NULL
a	NULL
1	NULL
LL	NULL
a2	NULL
$	NULL
1	NULL
>	NULL
|	NULL
NF	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
NF-IL6é	NULL
IS	NULL
IMPORTANT	NULL
FOR	NULL
proIL-18	NULL
GENE	NULL
EXPRESSION	NULL
1341	NULL
TABLE	NULL
2	NULL
.	NULL

Summary	NULL
of	NULL
CAT	NULL
data	NULL
for	NULL
mutated	NULL
P	NULL
;	NULL
Xho/fos	NULL
CAT	NULL
proIL-18	NULL
constructs	NULL
Cell	NULL
line	NULL
fos	NULL
CAT	NULL
Binding	NULL
site	NULL
CAT	NULL
activity	NULL
``	NULL
Relative	NULL
LPS	NULL
induced	NULL
transfected	NULL
construct	NULL
mutated	NULL
Uninduced	NULL
LPS	NULL
induced	NULL
CAT	NULL
(	NULL
%	NULL
)	NULL
RAW	NULL
264.7	NULL
P	NULL
;	NULL
Xho	NULL
None	NULL
46	NULL
+	NULL
28	NULL
(	NULL
10	NULL
)	NULL
280	NULL
+	NULL
70	NULL
(	NULL
10	NULL
)	NULL
100	NULL
P	NULL
;	NULL
Xho	NULL
IL6/Im	NULL
IL6	NULL
18	NULL
+	NULL
9	NULL
(	NULL
4	NULL
)	NULL
98	NULL
+	NULL
68	NULL
(	NULL
4	NULL
)	NULL
35	NULL
P	NULL
;	NULL
XhoAIL6/I	NULL
IL6	NULL
15	NULL
+	NULL
8	NULL
(	NULL
5	NULL
)	NULL
127	NULL
+	NULL
34	NULL
(	NULL
5	NULL
)	NULL
45	NULL
P	NULL
;	NULL
Xho	NULL
Blm	NULL
Bl	NULL
15	NULL
+	NULL
6	NULL
(	NULL
4	NULL
)	NULL
125	NULL
+	NULL
32	NULL
(	NULL
4	NULL
)	NULL
45	NULL
P	NULL
;	NULL
Xho	NULL
B2m	NULL
B2	NULL
45	NULL
+	NULL
7	NULL
(	NULL
2	NULL
)	NULL
313	NULL
+	NULL
170	NULL
(	NULL
2	NULL
)	NULL
112	NULL
fos	NULL
CAT	NULL
control	NULL
4	NULL
+	NULL
1	NULL
(	NULL
6	NULL
)	NULL
4	NULL
+	NULL
2	NULL
(	NULL
6	NULL
)	NULL
1.4	NULL
THP-1	NULL
P	NULL
;	NULL
Xho	NULL
None	NULL
9	NULL
+	NULL
6	NULL
(	NULL
5	NULL
)	NULL
79	NULL
+	NULL
38	NULL
(	NULL
5	NULL
)	NULL
100	NULL
P	NULL
;	NULL
XhoAIL6/I	NULL
IL6	NULL
6	NULL
(	NULL
1	NULL
)	NULL
24	NULL
+	NULL
7	NULL
(	NULL
2	NULL
)	NULL
30	NULL
fos	NULL
CAT	NULL
control	NULL
9	NULL
+	NULL
9	NULL
(	NULL
8	NULL
)	NULL
9	NULL
+	NULL
5	NULL
(	NULL
8	NULL
)	NULL
11	NULL
``	NULL
Calculated	NULL
as	NULL
described	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
footnote	NULL
a	NULL
.	NULL

A	NULL
and	NULL
B	NULL
and	NULL
with	NULL
adjacent	NULL
downstream	NULL
sequences	NULL
located	NULL
in	NULL
regions	NULL
F	NULL
through	NULL
I	NULL
to	NULL
support	NULL
a	NULL
maximal	NULL
response	NULL
.	NULL

The	NULL
P	NULL
;	NULL
Xho-inducible	NULL
activation	NULL
region	NULL
appears	NULL
to	NULL
be	NULL
cell	NULL
type	NULL
independent	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
non-prolIL-1B	NULL
promoter	NULL
(	NULL
murine	NULL
c-fos	NULL
promoter	NULL
)	NULL
but	NULL
is	NULL
sensitive	NULL
to	NULL
cell	NULL
type	NULL
when	NULL
associated	NULL
with	NULL
its	NULL
cognate	NULL
promoter	NULL
.	NULL

Therefore	NULL
,	NULL
this	NULL
cell	NULL
type	NULL
specificity	NULL
does	NULL
not	NULL
reside	NULL
exclusively	NULL
within	NULL
the	NULL
proIL-1B	NULL
enhancer	NULL
region	NULL
but	NULL
rather	NULL
requires	NULL
the	NULL
prolIL-1B	NULL
promoter	NULL
.	NULL

This	NULL
promoter	NULL
can	NULL
also	NULL
demonstrate	NULL
cell	NULL
specificity	NULL
when	NULL
associated	NULL
with	NULL
the	NULL
noncognate	NULL
SV40	NULL
enhancer	NULL
(	NULL
Table	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
tissue	NULL
specificity	NULL
for	NULL
proIL-1B	NULL
gene	NULL
transcription	NULL
may	NULL
reside	NULL
proximal	NULL
to	NULL
the	NULL
promoter	NULL
between	NULL
positions	NULL
-131	NULL
and	NULL
+12	NULL
.	NULL

Important	NULL
regions	NULL
also	NULL
exist	NULL
between	NULL
-2729	NULL
and	NULL
-1097	NULL
as	NULL
well	NULL
as	NULL
between	NULL
-1097	NULL
and	NULL
-131	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
decreased	NULL
activity	NULL
of	NULL
the	NULL
two	NULL
internal	NULL
deletion	NULL
constructs	NULL
(	NULL
P	NULL
;	NULL
Xho/PT	NULL
and	NULL
P	NULL
;	NULL
Xho/HT	NULL
)	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
transfection	NULL
data	NULL
presented	NULL
here	NULL
contrast	NULL
with	NULL
those	NULL
previously	NULL
reported	NULL
by	NULL
Bensi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
5	NULL
)	NULL
in	NULL
several	NULL
ways	NULL
.	NULL

First	NULL
,	NULL
both	NULL
the	NULL
THP-1	NULL
and	NULL
the	NULL
RAW	NULL
264.7	NULL
cells	NULL
used	NULL
in	NULL
this	NULL
study	NULL
,	NULL
unlike	NULL
the	NULL
THP-1	NULL
derivative	NULL
cell	NULL
line	NULL
described	NULL
by	NULL
Bensi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
exhibit	NULL
endogenous	NULL
prolIL-1B	NULL
mRNA	NULL
synthesis	NULL
in	NULL
response	NULL
to	NULL
treatment	NULL
with	NULL
LPS	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
previous	NULL
report	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
transfected	NULL
constructs	NULL
are	NULL
LPS	NULL
responsive	NULL
.	NULL

The	NULL
LPS-responsive	NULL
region	NULL
reported	NULL
here	NULL
(	NULL
P	NULL
;	NULL
Xho	NULL
plus	NULL
the	NULL
additional	NULL
upstream	NULL
region	NULL
A	NULL
)	NULL
extends	NULL
as	NULL
much	NULL
as	NULL
775	NULL
bp	NULL
farther	NULL
upstream	NULL
than	NULL
does	NULL
the	NULL
previously	NULL
reported	NULL
PMA-responsive	NULL
region	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
LPS-specific	NULL
transcriptional	NULL
activity	NULL
for	NULL
a	NULL
construct	NULL
containing	NULL
the	NULL
PMA-responsive	NULL
region	NULL
of	NULL
Bensi	NULL
et	NULL
al	NULL
.	NULL

but	NULL
lacking	NULL
the	NULL
additional	NULL
upstream	NULL
sequences	NULL
reported	NULL
here	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
construct	NULL
-2987T1	NULL
)	NULL
is	NULL
only	NULL
20	NULL
%	NULL
of	NULL
that	NULL
observed	NULL
when	NULL
the	NULL
additional	NULL
sequences	NULL
are	NULL
present	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
construct	NULL
XT	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
earlier	NULL
study	NULL
failed	NULL
to	NULL
note	NULL
the	NULL
functional	NULL
segmentation	NULL
of	NULL
the	NULL
region	NULL
and	NULL
the	NULL
apparent	NULL
cooperativity	NULL
of	NULL
these	NULL
multiple	NULL
elements	NULL
as	NULL
well	NULL
as	NULL
the	NULL
requirement	NULL
for	NULL
the	NULL
cap	NULL
site-proximal	NULL
sequences	NULL
in	NULL
establishing	NULL
tissue	NULL
specificity	NULL
or	NULL
maximal	NULL
activity	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
some	NULL
of	NULL
these	NULL
differences	NULL
relate	NULL
to	NULL
distinctions	NULL
among	NULL
the	NULL
cell	NULL
types	NULL
used	NULL
,	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
induction	NULL
agents	NULL
,	NULL
and	NULL
the	NULL
conditions	NULL
used	NULL
to	NULL
maintain	NULL
the	NULL
cells	NULL
.	NULL

For	NULL
example	NULL
,	NULL
as	NULL
mentioned	NULL
above	NULL
,	NULL
we	NULL
have	NULL
carefully	NULL
monitored	NULL
endotoxin	NULL
levels	NULL
throughout	NULL
all	NULL
procedures	NULL
in	NULL
order	NULL
to	NULL
minimize	NULL
induction	NULL
artifacts	NULL
.	NULL

Our	NULL
observation	NULL
that	NULL
primary	NULL
human	NULL
dermal	NULL
fibroblasts	NULL
transiently	NULL
transfected	NULL
with	NULL
constructs	NULL
3M	NULL
-	NULL
P	NULL
;	NULL
T	NULL
and	NULL
3M	NULL
-	NULL
XT	NULL
respond	NULL
to	NULL
induction	NULL
by	NULL
IL-1B	NULL
protein	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
demonstrates	NULL
that	NULL
the	NULL
P	NULL
;	NULL
Xho	NULL
fragment	NULL
contains	NULL
a	NULL
target	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
LPS	NULL
and	NULL
PMA	NULL
and	NULL
possibly	NULL
also	NULL
IL-1f	NULL
protein	NULL
.	NULL

Table	NULL
1	NULL
shows	NULL
that	NULL
in	NULL
THP-1	NULL
cells	NULL
,	NULL
the	NULL
response	NULL
of	NULL
the	NULL
P	NULL
;	NULL
Xho/fos	NULL
CAT	NULL
construct	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
the	NULL
murine	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
3M	NULL
-	NULL
P	NULL
,	NULL
;	NULL
T	NULL
and	NULL
3M	NULL
-	NULL
P	NULL
;	NULL
Xho/PT	NULL
CAT	NULL
constructs	NULL
are	NULL
not	NULL
inducible	NULL
in	NULL
THP-1	NULL
cells	NULL
,	NULL
whereas	NULL
they	NULL
are	NULL
inducible	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
and	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
the	NULL
possible	NULL
involvement	NULL
of	NULL
a	NULL
transcriptional	NULL
silencer	NULL
in	NULL
THP-1	NULL
cells	NULL
located	NULL
between	NULL
-1097	NULL
and	NULL
+12	NULL
along	NULL
with	NULL
the	NULL
potential	NULL
activation	NULL
sites	NULL
.	NULL

This	NULL
is	NULL
true	NULL
both	NULL
for	NULL
constitutively	NULL
expressing	NULL
electroporated	NULL
cells	NULL
and	NULL
for	NULL
the	NULL
inducible	NULL
DEAE-dextran-transfected	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
earlier	NULL
observation	NULL
that	NULL
a	NULL
THP-1	NULL
silencer	NULL
activity	NULL
may	NULL
be	NULL
overcome	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
first	NULL
intervening	NULL
sequence	NULL
in	NULL
the	NULL
proIL-1f	NULL
gene	NULL
(	NULL
3	NULL
,	NULL
5	NULL
)	NULL
suggests	NULL
that	NULL
additional	NULL
sequences	NULL
may	NULL
be	NULL
essential	NULL
to	NULL
completely	NULL
reconstitute	NULL
normal	NULL
gene	NULL
function	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
human	NULL
fibroblast	NULL
studies	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
contrast	NULL
with	NULL
the	NULL
THP-1	NULL
transfection	NULL
results	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
in	NULL
that	NULL
3M	NULL
«	NULL
P	NULL
;	NULL
T	NULL
and	NULL
3M	NULL
-	NULL
XT	NULL
generated	NULL
a	NULL
substantially	NULL
greater	NULL
induction	NULL
,	NULL
suggesting	NULL
that	NULL
either	NULL
cell	NULL
type	NULL
or	NULL
stimulus	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
LPS	NULL
versus	NULL
mature	NULL
IL-1f	NULL
protein	NULL
)	NULL
may	NULL
affect	NULL
the	NULL
degree	NULL
to	NULL
which	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
downstream	NULL
suppressive	NULL
region	NULL
is	NULL
counteracted	NULL
.	NULL

The	NULL
P	NULL
;	NULL
Xho	NULL
fragment	NULL
contains	NULL
a	NULL
recognition	NULL
site	NULL
which	NULL
resembles	NULL
that	NULL
of	NULL
the	NULL
human	NULL
NF-IL6	NULL
factor	NULL
(	NULL
2	NULL
)	NULL
,	NULL
which	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
murine	NULL
C/EBP3	NULL
(	NULL
6	NULL
)	NULL
and	NULL
IL-6DBP	NULL
in	NULL
the	NULL
rat	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
human	NULL
NF-IL6	NULL
factor	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
composed	NULL
of	NULL
at	NULL
least	NULL
two	NULL
C/EBP	NULL
-like	NULL
proteins	NULL
(	NULL
C/EBPRB	NULL
and	NULL
C/EBPy	NULL
)	NULL
,	NULL
which	NULL
can	NULL
form	NULL
homo-	NULL
and	NULL
heterodimers	NULL
(	NULL
6	NULL
,	NULL
27	NULL
,	NULL
49	NULL
)	NULL
.	NULL

At	NULL
least	NULL
one	NULL
of	NULL
the	NULL
NF-IL6	NULL
proteins	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
form	NULL
a	NULL
complex	NULL
with	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
NF-IL6	NULL
factors	NULL
have	NULL
been	NULL
postulated	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
and	NULL
LPS	NULL
activation	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
site	NULL
for	NULL
this	NULL
factor	NULL
in	NULL
the	NULL
proIL-18	NULL
gene	NULL
is	NULL
located	NULL
within	NULL
the	NULL
functionally	NULL
essential	NULL
region	NULL
E.	NULL
An	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

EMSA	NULL
using	NULL
radiolabeled	NULL
probes	NULL
M1	NULL
,	NULL
B1	NULL
,	NULL
and	NULL
B2	NULL
(	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
derived	NULL
from	NULL
THP-1	NULL
cells	NULL
treated	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
45	NULL
min	NULL
.	NULL

Unlabeled	NULL
competitors	NULL
shown	NULL
above	NULL
each	NULL
lane	NULL
were	NULL
used	NULL
in	NULL
molar	NULL
excess	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
figures	NULL
within	NULL
parentheses	NULL
.	NULL

The	NULL
A/lul-cut	NULL
pUC	NULL
nonspecific	NULL
competitor	NULL
used	NULL
in	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
represents	NULL
an	NULL
equimolar	NULL
mixture	NULL
of	NULL
five	NULL
fragments	NULL
ranging	NULL
between	NULL
136	NULL
and	NULL
93	NULL
bp	NULL
in	NULL
length	NULL
derived	NULL
by	NULL
preparative	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
of	NULL
a	NULL
complete	NULL
Alul	NULL
digest	NULL
of	NULL
plasmid	NULL
pUC19	NULL
.	NULL

The	NULL
cold	NULL
competitor	NULL
labeled	NULL
B3	NULL
corresponds	NULL
to	NULL
DNA	NULL
sequence	NULL
located	NULL
between	NULL
-2945	NULL
and	NULL
-2922	NULL
,	NULL
which	NULL
appears	NULL
to	NULL
be	NULL
unrelated	NULL
to	NULL
either	NULL
the	NULL
NFBI1	NULL
or	NULL
NFB2	NULL
sequence	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Probe	NULL
M1	NULL
;	NULL
(	NULL
B	NULL
)	NULL
probe	NULL
B2	NULL
;	NULL
(	NULL
C	NULL
)	NULL
probe	NULL
Bl	NULL
.	NULL

1342	NULL
SHIRAKAWA	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

TABLE	NULL
3	NULL
.	NULL

CAT	NULL
data	NULL
for	NULL
PMA	NULL
and	NULL
IL-18	NULL
protein	NULL
induction	NULL
of	NULL
transfected	NULL
prolL-1B	NULL
constructs	NULL
CAT	NULL
Inducer	NULL
(	NULL
concn	NULL
used	NULL
CAT	NULL
activity	NULL
``	NULL
Cell	NULL
type	NULL
transfected	NULL
construct	NULL
[	NULL
ng/m1	NULL
]	NULL
)	NULL
Uninduced	NULL
Induced	NULL
Primary	NULL
fibroblast	NULL
3M	NULL
-	NULL
P	NULL
,	NULL
T	NULL
IL-18B	NULL
(	NULL
0.1	NULL
)	NULL
7	NULL
+	NULL
3	NULL
(	NULL
4	NULL
)	NULL
15	NULL
+	NULL
8	NULL
(	NULL
4	NULL
)	NULL
3M	NULL
-	NULL
XT	NULL
IL-18B	NULL
(	NULL
0.1	NULL
)	NULL
4	NULL
(	NULL
1	NULL
)	NULL
11	NULL
(	NULL
1	NULL
)	NULL
3M	NULL
-	NULL
XT	NULL
IL-18	NULL
(	NULL
1	NULL
)	NULL
4	NULL
(	NULL
1	NULL
)	NULL
25	NULL
(	NULL
1	NULL
)	NULL
3M	NULL
-	NULL
XT	NULL
IL-18B	NULL
(	NULL
10	NULL
)	NULL
4	NULL
(	NULL
1	NULL
)	NULL
40	NULL
(	NULL
1	NULL
)	NULL
RAW	NULL
264.7	NULL
PMA	NULL
(	NULL
200	NULL
)	NULL
22	NULL
(	NULL
1	NULL
)	NULL
58	NULL
(	NULL
1	NULL
)	NULL
P	NULL
;	NULL
Xho/fos	NULL
PMA	NULL
(	NULL
1,000	NULL
)	NULL
22	NULL
(	NULL
1	NULL
)	NULL
78	NULL
(	NULL
1	NULL
)	NULL
HeLa	NULL
P	NULL
;	NULL
Xho/fos	NULL
PMA	NULL
(	NULL
50	NULL
)	NULL
372	NULL
+	NULL
95	NULL
(	NULL
3	NULL
)	NULL
2,005	NULL
+	NULL
123	NULL
(	NULL
3	NULL
)	NULL
P	NULL
;	NULL
Xho/HT	NULL
PMA	NULL
(	NULL
50	NULL
)	NULL
10	NULL
+	NULL
0	NULL
(	NULL
2	NULL
)	NULL
10	NULL
+	NULL
4	NULL
(	NULL
2	NULL
)	NULL
``	NULL
Calculated	NULL
as	NULL
described	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
footnote	NULL
a.	NULL
EMSA	NULL
using	NULL
DNA	NULL
from	NULL
this	NULL
region	NULL
reveals	NULL
that	NULL
the	NULL
binding	NULL
to	NULL
the	NULL
IL-1	NULL
sequence	NULL
is	NULL
indistinguishable	NULL
from	NULL
that	NULL
observed	NULL
with	NULL
use	NULL
of	NULL
the	NULL
reported	NULL
NF-IL6	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
band	NULL
shift	NULL
observed	NULL
in	NULL
the	NULL
EMSA	NULL
using	NULL
the	NULL
IL-1	NULL
oligonucleotide	NULL
not	NULL
only	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
reported	NULL
elsewhere	NULL
(	NULL
2	NULL
,	NULL
25	NULL
)	NULL
but	NULL
also	NULL
is	NULL
competed	NULL
for	NULL
by	NULL
the	NULL
bona	NULL
fide	NULL
NF-IL6	NULL
oligonucleotide	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
an	NULL
NF-IL6-related	NULL
factor	NULL
is	NULL
indeed	NULL
binding	NULL
to	NULL
this	NULL
essential	NULL
region	NULL
.	NULL

The	NULL
P	NULL
;	NULL
Xho/fos	NULL
CAT	NULL
plasmid	NULL
mutants	NULL
,	NULL
containing	NULL
either	NULL
the	NULL
NF-IL6/Im	NULL
base	NULL
pair	NULL
substitutions	NULL
which	NULL
reduce	NULL
the	NULL
binding	NULL
of	NULL
this	NULL
factor	NULL
or	NULL
a	NULL
deletion	NULL
of	NULL
the	NULL
entire	NULL
NF-IL6	NULL
binding	NULL
site	NULL
,	NULL
show	NULL
a	NULL
55	NULL
to	NULL
65	NULL
%	NULL
decrease	NULL
in	NULL
LPS-inducible	NULL
activity	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
and	NULL
a	NULL
79	NULL
%	NULL
decrease	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

This	NULL
finding	NULL
demonstrates	NULL
that	NULL
the	NULL
NF-IL6	NULL
factor	NULL
has	NULL
a	NULL
functional	NULL
role	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
activity	NULL
is	NULL
not	NULL
completely	NULL
abrogated	NULL
by	NULL
the	NULL
NF-IL6	NULL
binding	NULL
site	NULL
deletion	NULL
suggests	NULL
a	NULL
strong	NULL
but	NULL
partial	NULL
role	NULL
in	NULL
activity	NULL
.	NULL

We	NULL
have	NULL
observed	NULL
that	NULL
the	NULL
NF-IL6	NULL
factor	NULL
is	NULL
present	NULL
in	NULL
significant	NULL
amounts	NULL
prior	NULL
to	NULL
LPS	NULL
treatment	NULL
and	NULL
that	NULL
the	NULL
kinetics	NULL
of	NULL
the	NULL
LPS-dependent	NULL
increase	NULL
in	NULL
NF-IL6	NULL
factor	NULL
binding	NULL
in	NULL
THP-1	NULL
cell	NULL
nuclear	NULL
extracts	NULL
do	NULL
not	NULL
correlate	NULL
with	NULL
our	NULL
earlier	NULL
reported	NULL
(	NULL
15	NULL
)	NULL
rate	NULL
of	NULL
transcriptional	NULL
induction	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
significant	NULL
amounts	NULL
of	NULL
this	NULL
factor	NULL
prior	NULL
to	NULL
induction	NULL
and	NULL
the	NULL
inactivity	NULL
of	NULL
a	NULL
construct	NULL
containing	NULL
the	NULL
NF-IL6	NULL
binding	NULL
site	NULL
(	NULL
construct	NULL
9	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
suggest	NULL
that	NULL
other	NULL
cooperating	NULL
factors	NULL
are	NULL
involved	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
factor	NULL
by	NULL
unstimulated	NULL
cells	NULL
is	NULL
not	NULL
inconsistent	NULL
with	NULL
an	NULL
involvement	NULL
in	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
LPS	NULL
induction	NULL
,	NULL
since	NULL
the	NULL
NF-IL6	NULL
factor	NULL
could	NULL
require	NULL
posttrans-lational	NULL
modification	NULL
or	NULL
the	NULL
association	NULL
with	NULL
other	NULL
protein	NULL
factors	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
NF-IL6	NULL
in	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
prolL-18	NULL
broadens	NULL
the	NULL
range	NULL
for	NULL
this	NULL
factor	NULL
to	NULL
yet	NULL
another	NULL
gene	NULL
involved	NULL
in	NULL
the	NULL
manifestation	NULL
of	NULL
the	NULL
acute-phase	NULL
response	NULL
which	NULL
alters	NULL
an	NULL
organism	NULL
's	NULL
physiology	NULL
in	NULL
response	NULL
to	NULL
inflammatory	NULL
stress	NULL
.	NULL

The	NULL
other	NULL
two	NULL
factors	NULL
which	NULL
bind	NULL
to	NULL
the	NULL
P	NULL
;	NULL
Xho	NULL
fragment	NULL
include	NULL
NF-B1	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
a	NULL
sequence	NULL
resembling	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
factor	NULL
IRF-1	NULL
,	NULL
and	NULL
the	NULL
immediately	NULL
adjacent	NULL
novel	NULL
NF-B2	NULL
binding	NULL
site	NULL
.	NULL

Factor	NULL
IRF-1	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
beta	NULL
interferon	NULL
gene	NULL
,	NULL
which	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
virus	NULL
,	NULL
IL-1	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
,	NULL
and	NULL
colony-stimulating	NULL
factor	NULL
1	NULL
(	NULL
17	NULL
,	NULL
22	NULL
)	NULL
.	NULL

This	NULL
factor	NULL
,	NULL
which	NULL
was	NULL
originally	NULL
defined	NULL
in	NULL
terms	NULL
of	NULL
its	NULL
binding	NULL
half-sequence	NULL
(	NULL
the	NULL
hexamer	NULL
motif	NULL
)	NULL
(	NULL
17	NULL
)	NULL
,	NULL
has	NULL
recently	NULL
been	NULL
characterized	NULL
(	NULL
34	NULL
)	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
stimuli	NULL
such	NULL
as	NULL
lectins	NULL
and	NULL
LPS	NULL
as	NULL
well	NULL
as	NULL
by	NULL
various	NULL
cytokines	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
NF-B1	NULL
appears	NULL
to	NULL
bind	NULL
to	NULL
a	NULL
region	NULL
containing	NULL
a	NULL
single	NULL
hexamer	NULL
motif	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
an	NULL
IRF-1	NULL
half-site	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
suggests	NULL
the	NULL
possibility	NULL
that	NULL
NF-B1	NULL
consists	NULL
of	NULL
an	NULL
IRF-1-related	NULL
protein	NULL
heterodimer	NULL
.	NULL

The	NULL
modification	NULL
of	NULL
the	NULL
Blm	NULL
site	NULL
appears	NULL
to	NULL
have	NULL
a	NULL
negative	NULL
effect	NULL
on	NULL
activity	NULL
,	NULL
whereas	NULL
the	NULL
B2m	NULL
mutation	NULL
results	NULL
in	NULL
a	NULL
slight	NULL
activity	NULL
increase	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

Two	NULL
downstream	NULL
deletion	NULL
constructs	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
(	NULL
constructs	NULL
3	NULL
and	NULL
4	NULL
)	NULL
support	NULL
the	NULL
minimal	NULL
importance	NULL
of	NULL
the	NULL
B2	NULL
site	NULL
relative	NULL
to	NULL
that	NULL
of	NULL
Bl	NULL
.	NULL

Like	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
NF-IL6	NULL
factor	NULL
,	NULL
the	NULL
bindings	NULL
of	NULL
NF-B1	NULL
and	NULL
NF-B2	NULL
are	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
stimulation	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
mutation	NULL
and	NULL
deletion	NULL
data	NULL
presented	NULL
here	NULL
support	NULL
a	NULL
preliminary	NULL
model	NULL
in	NULL
which	NULL
NF-IL6	NULL
binds	NULL
to	NULL
region	NULL
E	NULL
and	NULL
additional	NULL
factors	NULL
bind	NULL
to	NULL
regions	NULL
A	NULL
through	NULL
C	NULL
as	NULL
well	NULL
as	NULL
to	NULL
regions	NULL
F	NULL
through	NULL
I	NULL
.	NULL

These	NULL
factors	NULL
are	NULL
each	NULL
necessary	NULL
,	NULL
but	NULL
TABLE	NULL
4	NULL
.	NULL

Cell	NULL
specificity	NULL
of	NULL
transfected	NULL
human	NULL
proIL-1B	NULL
gene	NULL
sequences	NULL
Induced	NULL
CAT	NULL
``	NULL
Fold	NULL
CAT	NULL
over	NULL
control	NULL
CAT	NULL
construct	NULL
Promoter	NULL
Enhancer	NULL
RAW	NULL
264.7	NULL
(	NULL
LPS	NULL
)	NULL
HeLa	NULL
(	NULL
PMA	NULL
)	NULL
RAW	NULL
264.7	NULL
(	NULL
LPS	NULL
)	NULL
HeLa	NULL
(	NULL
PMA	NULL
)	NULL
Test	NULL
plasmids	NULL
P	NULL
;	NULL
Xho/fos	NULL
c-fos	NULL
proIL1fB	NULL
280	NULL
+	NULL
70	NULL
(	NULL
10	NULL
)	NULL
2,005	NULL
+	NULL
123	NULL
(	NULL
3	NULL
)	NULL
76	NULL
41	NULL
3M	NULL
-	NULL
P	NULL
;	NULL
Xho/HT	NULL
proIL1g	NULL
``	NULL
proIL1g	NULL
``	NULL
27	NULL
+	NULL
9	NULL
(	NULL
3	NULL
)	NULL
9.7	NULL
+	NULL
4.1	NULL
(	NULL
2	NULL
)	NULL
8	NULL
1.0	NULL
3ME	NULL
-	NULL
HT	NULL
proIL1g	NULL
``	NULL
SV40	NULL
79	NULL
(	NULL
1	NULL
)	NULL
11	NULL
(	NULL
1	NULL
)	NULL
20	NULL
0.7	NULL
pSVzCAT	NULL
SV40	NULL
early	NULL
SV40	NULL
216	NULL
(	NULL
1	NULL
)	NULL
2,346	NULL
+	NULL
789	NULL
(	NULL
3	NULL
)	NULL
°	NULL
54	NULL
147	NULL
Controls	NULL
fos	NULL
vector	NULL
c-fos	NULL
None	NULL
3.7	NULL
+	NULL
0.1	NULL
(	NULL
2	NULL
)	NULL
49	NULL
+	NULL
5.8	NULL
(	NULL
2	NULL
)	NULL
3M	NULL
vector	NULL
None	NULL
None	NULL
3.5	NULL
+	NULL
1.6	NULL
(	NULL
6	NULL
)	NULL
10	NULL
+	NULL
0.7	NULL
(	NULL
2	NULL
)	NULL
3ME	NULL
vector	NULL
None	NULL
SV40	NULL
4.0	NULL
(	NULL
1	NULL
)	NULL
16	NULL
(	NULL
1	NULL
)	NULL
``	NULL
Calculated	NULL
as	NULL
described	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
footnote	NULL
a	NULL
.	NULL

RAW	NULL
264.7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
CaPO	NULL
,	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
DEAE-dextran	NULL
.	NULL

The	NULL
fos	NULL
and	NULL
3M	NULL
vectors	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
for	NULL
P	NULL
;	NULL
Xho/fos	NULL
and	NULL
3M	NULL
-	NULL
P	NULL
;	NULL
Xho/HT	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
3ME	NULL
vector	NULL
contains	NULL
the	NULL
SV40	NULL
enhancer	NULL
sequence	NULL
and	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
the	NULL
normalization	NULL
of	NULL
both	NULL
the	NULL
3ME	NULL
-	NULL
HT	NULL
and	NULL
the	NULL
pSV2CAT	NULL
data	NULL
.	NULL

``	NULL
The	NULL
proIL1B	NULL
promoter	NULL
and	NULL
enhancer	NULL
used	NULL
sequences	NULL
located	NULL
between	NULL
-131	NULL
to	NULL
+12	NULL
and	NULL
-3132	NULL
to	NULL
-2729	NULL
,	NULL
respectively	NULL
.	NULL

©	NULL
Unstimulated	NULL
value	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
no	NULL
PMA	NULL
added	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
insufficient	NULL
,	NULL
for	NULL
gene	NULL
induction	NULL
.	NULL

Preliminary	NULL
EMSA	NULL
analysis	NULL
suggests	NULL
that	NULL
at	NULL
least	NULL
three	NULL
additional	NULL
factors	NULL
bind	NULL
to	NULL
the	NULL
B	NULL
through	NULL
C	NULL
region	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Such	NULL
interdependence	NULL
among	NULL
discrete	NULL
factors	NULL
is	NULL
not	NULL
novel	NULL
and	NULL
has	NULL
been	NULL
described	NULL
for	NULL
other	NULL
transcription	NULL
systems	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
Drouet	NULL
et	NULL
al	NULL
.	NULL

(	NULL
13a	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
three	NULL
of	NULL
four	NULL
cooperating	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
must	NULL
be	NULL
eliminated	NULL
in	NULL
order	NULL
to	NULL
significantly	NULL
decrease	NULL
the	NULL
LPS	NULL
induction	NULL
of	NULL
the	NULL
murine	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
gene	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
mutation	NULL
of	NULL
a	NULL
single	NULL
binding	NULL
site	NULL
for	NULL
genes	NULL
requiring	NULL
multiple	NULL
transcription	NULL
factor	NULL
associations	NULL
is	NULL
not	NULL
necessarily	NULL
sufficient	NULL
for	NULL
inactivation	NULL
.	NULL

A	NULL
screening	NULL
of	NULL
the	NULL
distribution	NULL
of	NULL
the	NULL
three	NULL
DNA-binding	NULL
factors	NULL
mentioned	NULL
above	NULL
has	NULL
been	NULL
initiated	NULL
by	NULL
using	NULL
the	NULL
EMSA	NULL
probes	NULL
described	NULL
in	NULL
this	NULL
study	NULL
to	NULL
test	NULL
for	NULL
binding	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
IL-l-treated	NULL
human	NULL
primary	NULL
dermal	NULL
fibroblasts	NULL
,	NULL
PMA-treated	NULL
HeLa	NULL
cells	NULL
,	NULL
and	NULL
untreated	NULL
COS	NULL
cells	NULL
(	NULL
40	NULL
)	NULL
.	NULL

As	NULL
a	NULL
result	NULL
,	NULL
it	NULL
appears	NULL
as	NULL
though	NULL
NF-B2-like	NULL
factors	NULL
are	NULL
abundant	NULL
in	NULL
all	NULL
these	NULL
cell	NULL
types	NULL
,	NULL
whereas	NULL
NF-B1	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
in	NULL
any	NULL
of	NULL
them	NULL
.	NULL

Like	NULL
NF-B2	NULL
,	NULL
NF-IL6-like	NULL
factors	NULL
(	NULL
as	NULL
judged	NULL
by	NULL
specific	NULL
binding	NULL
to	NULL
an	NULL
IL6/I	NULL
probe	NULL
)	NULL
are	NULL
present	NULL
in	NULL
all	NULL
of	NULL
the	NULL
cells	NULL
used	NULL
,	NULL
although	NULL
the	NULL
abundance	NULL
in	NULL
HeLa	NULL
and	NULL
COS	NULL
cells	NULL
appeared	NULL
to	NULL
be	NULL
significantly	NULL
less	NULL
than	NULL
in	NULL
fibroblasts	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
NF-IL6/I-binding	NULL
factors	NULL
in	NULL
all	NULL
of	NULL
these	NULL
cells	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
P	NULL
;	NULL
Xho/fos	NULL
construct	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Table	NULL
4	NULL
)	NULL
.	NULL

The	NULL
apparent	NULL
lack	NULL
of	NULL
NF-B1-like	NULL
binding	NULL
in	NULL
any	NULL
of	NULL
the	NULL
cells	NULL
tested	NULL
suggests	NULL
that	NULL
this	NULL
factor	NULL
may	NULL
not	NULL
be	NULL
essential	NULL
for	NULL
proIL-1B	NULL
gene	NULL
induction	NULL
in	NULL
IL-l-treated	NULL
fibroblasts	NULL
or	NULL
PMA-treated	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
IL-1	NULL
transcriptional	NULL
response	NULL
profile	NULL
fits	NULL
well	NULL
with	NULL
induction	NULL
by	NULL
other	NULL
well-known	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
AP-1	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
NF-kB	NULL
.	NULL

A	NULL
search	NULL
of	NULL
the	NULL
sequence	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
suggests	NULL
the	NULL
presence	NULL
of	NULL
several	NULL
sequence	NULL
motifs	NULL
which	NULL
may	NULL
serve	NULL
as	NULL
binding	NULL
sites	NULL
for	NULL
such	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Specific	NULL
internal	NULL
deletions	NULL
at	NULL
these	NULL
sites	NULL
will	NULL
be	NULL
required	NULL
to	NULL
establish	NULL
the	NULL
exact	NULL
role	NULL
of	NULL
each	NULL
of	NULL
these	NULL
factors	NULL
.	NULL

We	NULL
had	NULL
previously	NULL
reported	NULL
that	NULL
the	NULL
prolIL-1B	NULL
gene	NULL
promoter	NULL
is	NULL
contained	NULL
within	NULL
131	NULL
residues	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
47	NULL
)	NULL
,	NULL
is	NULL
highly	NULL
conserved	NULL
between	NULL
human	NULL
and	NULL
mouse	NULL
sequences	NULL
(	NULL
8	NULL
)	NULL
,	NULL
and	NULL
binds	NULL
a	NULL
protein	NULL
present	NULL
in	NULL
cells	NULL
competent	NULL
for	NULL
prolL-1B	NULL
gene	NULL
transcription	NULL
(	NULL
3	NULL
,	NULL
8	NULL
,	NULL
24	NULL
)	NULL
.	NULL

This	NULL
protein	NULL
,	NULL
which	NULL
we	NULL
have	NULL
designated	NULL
as	NULL
NF-BA	NULL
(	NULL
24	NULL
)	NULL
,	NULL
binds	NULL
to	NULL
a	NULL
conserved	NULL
sequence	NULL
(	NULL
ACTTCTGCTTTT	NULL
)	NULL
found	NULL
at	NULL
the	NULL
identical	NULL
location	NULL
in	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
genes	NULL
(	NULL
-49	NULL
to	NULL
-38	NULL
)	NULL
and	NULL
is	NULL
expressed	NULL
constitutively	NULL
in	NULL
competent	NULL
cells	NULL
but	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
refractory	NULL
cells	NULL
such	NULL
as	NULL
T	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
not	NULL
yet	NULL
clear	NULL
that	NULL
NF-BA	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
observed	NULL
tissue	NULL
specificity	NULL
,	NULL
since	NULL
a	NULL
recognition	NULL
sequence	NULL
for	NULL
a	NULL
factor	NULL
with	NULL
appropriate	NULL
tissue	NULL
specificity	NULL
,	NULL
the	NULL
hematopoi-etic	NULL
transcription	NULL
factor	NULL
Spi-1	NULL
(	NULL
equivalent	NULL
to	NULL
factor	NULL
B1	NULL
in	NULL
[	NULL
19	NULL
]	NULL
)	NULL
,	NULL
also	NULL
is	NULL
contained	NULL
within	NULL
the	NULL
131	NULL
residues	NULL
of	NULL
upstream	NULL
promoter-proximal	NULL
sequence	NULL
as	NULL
well	NULL
as	NULL
a	NULL
recently	NULL
reported	NULL
binding	NULL
site	NULL
for	NULL
NF-IL6	NULL
(	NULL
35	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
demonstrated	NULL
an	NULL
involvement	NULL
of	NULL
this	NULL
part	NULL
of	NULL
the	NULL
proIL-1f	NULL
gene	NULL
sequence	NULL
in	NULL
the	NULL
trans	NULL
activation	NULL
of	NULL
this	NULL
gene	NULL
by	NULL
the	NULL
IE1l	NULL
immediate-early	NULL
gene	NULL
product	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
(	NULL
HCMV	NULL
)	NULL
,	NULL
thus	NULL
explaining	NULL
the	NULL
strong	NULL
effect	NULL
of	NULL
HCMV	NULL
infection	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
IL-1	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
HCMV	NULL
IEl	NULL
trans	NULL
activation	NULL
is	NULL
enhanced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LPS	NULL
(	NULL
10	NULL
)	NULL
suggests	NULL
an	NULL
additional	NULL
complexity	NULL
to	NULL
the	NULL
nature	NULL
of	NULL
proIL-1B	NULL
gene	NULL
regulation	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Homero	NULL
Rey	NULL
,	NULL
Marty	NULL
M.	NULL
Monick	NULL
,	NULL
and	NULL
Wayne	NULL
Waterman	NULL
as	NULL
well	NULL
as	NULL
Malcolm	NULL
Smith	NULL
,	NULL
Burton	NULL
D.	NULL
Clark	NULL
,	NULL
Mary	NULL
Vermeulen	NULL
,	NULL
and	NULL
Gary	NULL
W.	NULL
Hunninghake	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

NF-IL6	NULL
IS	NULL
IMPORTANT	NULL
FOR	NULL
prolL-1B	NULL
GENE	NULL
EXPRESSION	NULL
1343	NULL
We	NULL
thank	NULL
Stephen	NULL
M.	NULL
Krane	NULL
for	NULL
encouragement	NULL
,	NULL
facilities	NULL
,	NULL
and	NULL
support	NULL
(	NULL
AR-03564	NULL
)	NULL
.	NULL

The	NULL
support	NULL
of	NULL
John	NULL
T.	NULL
Potts	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
the	NULL
Chugai	NULL
Corporation	NULL
is	NULL
also	NULL
acknowledged	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
grants	NULL
Al27850	NULL
to	NULL
P.E.A	NULL
.	NULL

and	NULL
AI29088	NULL
to	NULL
M.J.F	NULL
.	NULL

F.S	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
postdoctoral	NULL
fellowship	NULL
from	NULL
the	NULL
Arthritis	NULL
Foundation	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

Biology	NULL
of	NULL
multifunctional	NULL
cytokines	NULL
:	NULL
IL	NULL
6	NULL
and	NULL
related	NULL
molecules	NULL
(	NULL
IL	NULL
1	NULL
and	NULL
TNF	NULL
)	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

4:2860-2867	NULL
.	NULL

2	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
T.	NULL
Sugita	NULL
,	NULL
O.	NULL
Tanabe	NULL
,	NULL
S.	NULL
Kinoshita	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
T.	NULL
Nakajima	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
for	NULL
IL-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
C/EBP	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:1897-1906	NULL
.	NULL

2a	NULL
.	NULL

Auron	NULL
,	NULL
P.	NULL
E.	NULL
Unpublished	NULL
data	NULL
.	NULL

3	NULL
.	NULL

Auron	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
M.	NULL
J.	NULL
Fenton	NULL
,	NULL
H.	NULL
L.	NULL
Rey	NULL
,	NULL
and	NULL
A.	NULL
C.	NULL
Webb	NULL
.	NULL

1989	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
pro-interleukin-1B	NULL
gene	NULL
transcription	NULL
.	NULL

Lymphokine	NULL
Receptor	NULL
Interact	NULL
.	NULL

179:61-66	NULL
.	NULL

4	NULL
.	NULL

Auron	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
S.	NULL
J.	NULL
C.	NULL
Warner	NULL
,	NULL
A.	NULL
C.	NULL
Webb	NULL
,	NULL
J.	NULL
G.	NULL
Cannon	NULL
,	NULL
H.	NULL
A.	NULL
Bernheim	NULL
,	NULL
K.	NULL
J.	NULL
P.	NULL
W.	NULL
McAdam	NULL
,	NULL
L.	NULL
J.	NULL
Rosenwasser	NULL
,	NULL
G.	NULL
Lo-Preste	NULL
,	NULL
S.	NULL
F.	NULL
Mucci	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Dinarello	NULL
.	NULL

1987	NULL
.	NULL

Studies	NULL
on	NULL
the	NULL
molecular	NULL
nature	NULL
of	NULL
human	NULL
interleukin	NULL
1	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

138:1447-1456	NULL
.	NULL

5	NULL
.	NULL

Bensi	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Mora	NULL
,	NULL
G.	NULL
Raugei	NULL
,	NULL
D.	NULL
T.	NULL
Buonamassa	NULL
,	NULL
M.	NULL
Rossini	NULL
,	NULL
and	NULL
M.	NULL
Melli	NULL
.	NULL

1990	NULL
.	NULL

An	NULL
inducible	NULL
enhancer	NULL
controls	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
interleukin	NULL
1B	NULL
gene	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

1:491-497	NULL
.	NULL

6	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
R.	NULL
M.	NULL
Umek	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1991	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
three	NULL
C/EBP	NULL
isoforms	NULL
during	NULL
adipose	NULL
conversion	NULL
of	NULL
3T3-L1	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:1538-1555	NULL
.	NULL

7	NULL
.	NULL

Clark	NULL
,	NULL
B.	NULL
D.	NULL
,	NULL
K.	NULL
L.	NULL
Collins	NULL
,	NULL
M.	NULL
S.	NULL
Gandy	NULL
,	NULL
A.	NULL
C.	NULL
Webb	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Auron	NULL
.	NULL

1986	NULL
.	NULL

Genomic	NULL
sequence	NULL
for	NULL
human	NULL
prointerleukin	NULL
1	NULL
beta	NULL
:	NULL
possible	NULL
evolution	NULL
from	NULL
a	NULL
reverse	NULL
transcribed	NULL
prointerleukin	NULL
1	NULL
alpha	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14:7897-7914	NULL
.	NULL

8	NULL
.	NULL

Clark	NULL
,	NULL
B.	NULL
D.	NULL
,	NULL
M.	NULL
J.	NULL
Fenton	NULL
,	NULL
H.	NULL
L.	NULL
Rey	NULL
,	NULL
A.	NULL
C.	NULL
Webb	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Auron	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
cis	NULL
and	NULL
trans	NULL
acting	NULL
elements	NULL
involved	NULL
in	NULL
human	NULL
proIL-1	NULL
beta	NULL
gene	NULL
expression	NULL
,	NULL
p.	NULL
47-53	NULL
.	NULL

In	NULL
M.	NULL
C.	NULL
Powanda	NULL
,	NULL
J.	NULL
J.	NULL
Oppenheim	NULL
,	NULL
M.	NULL
J.	NULL
Kluger	NULL
,	NULL
and	NULL
C.	NULL
Dinarello	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Monokines	NULL
and	NULL
other	NULL
non-lymphocytic	NULL
cyto-kines	NULL
.	NULL

Alan	NULL
R.	NULL
Liss	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

9	NULL
.	NULL

Conca	NULL
,	NULL
W.	NULL
,	NULL
P.	NULL
E.	NULL
Auron	NULL
,	NULL
M.	NULL
Aoun-Wathne	NULL
,	NULL
N.	NULL
Bennett	NULL
,	NULL
P.	NULL
Seckinger	NULL
,	NULL
H.	NULL
G.	NULL
Welgus	NULL
,	NULL
S.	NULL
R.	NULL
Goldring	NULL
,	NULL
S.	NULL
P.	NULL
Eisenberg	NULL
,	NULL
J.-M.	NULL
Dayer	NULL
,	NULL
S.	NULL
M.	NULL
Krane	NULL
,	NULL
and	NULL
L.	NULL
Gehrke	NULL
.	NULL

1991	NULL
.	NULL

An	NULL
interleukin	NULL
18	NULL
point	NULL
mutant	NULL
demonstrates	NULL
that	NULL
jun/fos	NULL
expression	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
fibroblast	NULL
metalloproteinase	NULL
expression	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:16265-16268	NULL
.	NULL

10	NULL
.	NULL

Crump	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
L.	NULL
J.	NULL
Geist	NULL
,	NULL
P.	NULL
E.	NULL
Auron	NULL
,	NULL
A.	NULL
C.	NULL
Webb	NULL
,	NULL
M.	NULL
F.	NULL
Stinski	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Hunninghake	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
immediate	NULL
early	NULL
genes	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
require	NULL
only	NULL
proximal	NULL
promoter	NULL
elements	NULL
to	NULL
upregulate	NULL
expression	NULL
of	NULL
interleukin-16	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

6:674-677	NULL
.	NULL

11	NULL
.	NULL

D'Eustachio	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
Jadidi	NULL
,	NULL
R.	NULL
Fublbrigge	NULL
,	NULL
P.	NULL
Gray	NULL
,	NULL
and	NULL
D.	NULL
Chaplin	NULL
.	NULL

1987	NULL
.	NULL

Interleukin-1	NULL
alpha	NULL
and	NULL
beta	NULL
genes	NULL
:	NULL
linkage	NULL
on	NULL
chromosome	NULL
2	NULL
in	NULL
the	NULL
mouse	NULL
.	NULL

Immunogenetics	NULL
26:339-343	NULL
.	NULL

12	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
cell	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

13	NULL
.	NULL

Dinarello	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

1991	NULL
.	NULL

Interleukin-1	NULL
and	NULL
interleukin-1	NULL
antago-nism	NULL
.	NULL

Blood	NULL
77:1627-1652	NULL
.	NULL

13a.Drouet	NULL
,	NULL
D.	NULL
,	NULL
A.	NULL
N.	NULL
Shakhov	NULL
,	NULL
and	NULL
C.	NULL
V.	NULL
Jongeneel	NULL
.	NULL

1991	NULL
.	NULL

Enhanc-ers	NULL
and	NULL
transcription	NULL
factors	NULL
controlling	NULL
the	NULL
inducibility	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
promoter	NULL
in	NULL
primary	NULL
macrophages	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:1694-1700	NULL
.	NULL

14	NULL
.	NULL

Dudding	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
B.	NULL
D.	NULL
Clark	NULL
,	NULL
P.	NULL
E.	NULL
Auron	NULL
,	NULL
S.	NULL
Sporn	NULL
,	NULL
and	NULL
E.-S.	NULL
Huang	NULL
.	NULL

1989	NULL
.	NULL

Cytomegalovirus	NULL
infection	NULL
stimulates	NULL
expression	NULL
of	NULL
monocyte-associated	NULL
mediator	NULL
genes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:3343-3352	NULL
.	NULL

15	NULL
.	NULL

Fenton	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
B.	NULL
D.	NULL
Clark	NULL
,	NULL
K.	NULL
L.	NULL
Collins	NULL
,	NULL
A.	NULL
C.	NULL
Webb	NULL
,	NULL
A	NULL
.	NULL

Rich	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Auron	NULL
.	NULL

1987	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
prointerleukin	NULL
1B	NULL
gene	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

138:3972-3979	NULL
.	NULL

16	NULL
.	NULL

Fenton	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
M.	NULL
W.	NULL
Vermeulen	NULL
,	NULL
B.	NULL
D.	NULL
Clark	NULL
,	NULL
A.	NULL
C.	NULL
Webb	NULL
,	NULL
and	NULL
1344	NULL
17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

SHIRAKAWA	NULL
ET	NULL
AL	NULL
.	NULL

P.	NULL
E.	NULL
Auron	NULL
.	NULL

1988	NULL
.	NULL

Human	NULL
pro-IL-18	NULL
gene	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
is	NULL
regulated	NULL
by	NULL
two	NULL
distinct	NULL
pathways	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:2267-2273	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Shibuya	NULL
,	NULL
H.	NULL
Hotta	NULL
,	NULL
K.	NULL
Yamanishi	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1987	NULL
.	NULL

Interferon-B	NULL
gene	NULL
regulation	NULL
:	NULL
tandemly	NULL
repeated	NULL
sequences	NULL
of	NULL
a	NULL
synthetic	NULL
6	NULL
bp	NULL
oligomer	NULL
function	NULL
as	NULL
a	NULL
virus-inducible	NULL
enhancer	NULL
.	NULL

Cell	NULL
49:357-367	NULL
.	NULL

Furutani	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Notake	NULL
,	NULL
T.	NULL
Fukui	NULL
,	NULL
M.	NULL
Ohue	NULL
,	NULL
H.	NULL
Nomura	NULL
,	NULL
M.	NULL
Yamada	NULL
,	NULL
and	NULL
S.	NULL
Nakamura	NULL
.	NULL

1986	NULL
.	NULL

Complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
human	NULL
interleukin-l-alpha	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14:3167-3179	NULL
.	NULL

Galson	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
D.	NULL
E.	NULL
Housman	NULL
.	NULL

1988	NULL
.	NULL

Detection	NULL
of	NULL
two	NULL
tissue-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
with	NULL
affinity	NULL
for	NULL
sites	NULL
in	NULL
the	NULL
mouse	NULL
B-globin	NULL
intervening	NULL
sequence	NULL
2	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:381-392	NULL
.	NULL

Giri	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
P.	NULL
T.	NULL
Lomedico	NULL
,	NULL
and	NULL
S.	NULL
B.	NULL
Mizel	NULL
.	NULL

1985	NULL
.	NULL

Studies	NULL
on	NULL
the	NULL
synthesis	NULL
and	NULL
secretion	NULL
of	NULL
interleukin	NULL
1	NULL
.	NULL

I	NULL
.	NULL

A	NULL
33,000	NULL
molecular	NULL
weight	NULL
precursor	NULL
for	NULL
interleukin	NULL
1	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

134:343-349	NULL
.	NULL

Goldring	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Krane	NULL
.	NULL

1987	NULL
.	NULL

Modulation	NULL
by	NULL
recombinant	NULL
interleukin	NULL
1	NULL
of	NULL
synthesis	NULL
of	NULL
types	NULL
I	NULL
and	NULL
III	NULL
collagens	NULL
and	NULL
associated	NULL
procollagen	NULL
mRNA	NULL
levels	NULL
in	NULL
cultured	NULL
human	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262:16724-16729	NULL
.	NULL

Harada	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
M.	NULL
Miyamato	NULL
,	NULL
Y.	NULL
Kimura	NULL
,	NULL
M.	NULL
Maruyama	NULL
,	NULL
A.	NULL
Furia	NULL
,	NULL
T.	NULL
Miyata	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1989	NULL
.	NULL

Structurally	NULL
similar	NULL
but	NULL
functionally	NULL
distinct	NULL
factors	NULL
,	NULL
IRF-1	NULL
and	NULL
IRF-2	NULL
,	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
regulatory	NULL
elements	NULL
of	NULL
IFN	NULL
and	NULL
IFN-inducible	NULL
genes	NULL
.	NULL

Cell	NULL
58:729-739	NULL
.	NULL

Higuchi	NULL
,	NULL
R.	NULL
1990	NULL
.	NULL

Recombinant	NULL
PCR	NULL
,	NULL
p.	NULL
177-183	NULL
.	NULL

In	NULL
M.	NULL
A.	NULL
Innis	NULL
,	NULL
D.	NULL
H.	NULL
Gelfand	NULL
,	NULL
J.	NULL
J.	NULL
Sninsky	NULL
,	NULL
and	NULL
T.	NULL
J	NULL
.	NULL

White	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
PCR	NULL
protocols	NULL
:	NULL
a	NULL
guide	NULL
to	NULL
methods	NULL
and	NULL
applications	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Hunninghake	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
B.	NULL
G.	NULL
Monks	NULL
,	NULL
L.	NULL
J.	NULL
Geist	NULL
,	NULL
M.	NULL
M.	NULL
Monick	NULL
,	NULL
M.	NULL
A.	NULL
Monroy	NULL
,	NULL
M.	NULL
F.	NULL
Stinski	NULL
,	NULL
A.	NULL
C.	NULL
Webb	NULL
,	NULL
J.-M.	NULL
Dayer	NULL
,	NULL
P.	NULL
E.	NULL
Auron	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Fenton	NULL
,	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
functional	NULL
importance	NULL
of	NULL
a	NULL
cap	NULL
site-proximal	NULL
region	NULL
of	NULL
the	NULL
human	NULL
prointerleukin	NULL
1B	NULL
gene	NULL
is	NULL
defined	NULL
by	NULL
viral	NULL
protein	NULL
frans-activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
:	NULL
3439-3448	NULL
.	NULL

Isshiki	NULL
,	NULL
H.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
T.	NULL
Sugita	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
S.	NULL
Hashimoto	NULL
,	NULL
T.	NULL
Pawlowski	NULL
,	NULL
S.	NULL
Suematsu	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1991	NULL
.	NULL

Reciprocal	NULL
expression	NULL
of	NULL
NF-IL6	NULL
and	NULL
C/EBP	NULL
in	NULL
hepatocytes	NULL
:	NULL
possible	NULL
involvement	NULL
of	NULL
NF-IL6	NULL
in	NULL
acute	NULL
phase	NULL
protein	NULL
gene	NULL
expression	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

3:63-70	NULL
.	NULL

Iwamoto	NULL
,	NULL
G.	NULL
K.	NULL
,	NULL
M.	NULL
M.	NULL
Monick	NULL
,	NULL
B.	NULL
D.	NULL
Clark	NULL
,	NULL
P.	NULL
E.	NULL
Auron	NULL
,	NULL
M.	NULL
F.	NULL
Stinski	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Hunninghake	NULL
.	NULL

1990	NULL
.	NULL

Modulation	NULL
of	NULL
interleukin-1	NULL
beta-gene	NULL
expression	NULL
by	NULL
the	NULL
immediate	NULL
early	NULL
genes	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

85:1853-1857	NULL
.	NULL

Kinoshita	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
,	NULL
NF-IL6B	NULL
,	NULL
forms	NULL
a	NULL
heterodimer	NULL
and	NULL
transcrip-tionally	NULL
synergizes	NULL
with	NULL
NF-IL6	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1473-1476	NULL
.	NULL

Kraft	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Tardiff	NULL
,	NULL
K.	NULL
S.	NULL
Krauter	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Leinwand	NULL
.	NULL

1988	NULL
.	NULL

Using	NULL
mini-prep	NULL
plasmid	NULL
DNA	NULL
for	NULL
sequencing	NULL
double	NULL
stranded	NULL
templates	NULL
with	NULL
sequenase	NULL
.	NULL

BioTechniques	NULL
6:544-547	NULL
.	NULL

Krane	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
W.	NULL
Conca	NULL
,	NULL
M.	NULL
L.	NULL
Stephenson	NULL
,	NULL
E.	NULL
P.	NULL
Amento	NULL
,	NULL
and	NULL
M.	NULL
B.	NULL
Goldring	NULL
.	NULL

1990	NULL
.	NULL

Mechanisms	NULL
of	NULL
matrix	NULL
degradation	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Ann	NULL
.	NULL

N.Y.	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

580:340-354	NULL
.	NULL

La	NULL
Fage	NULL
,	NULL
M.	NULL
,	NULL
N.	NULL
Maroc	NULL
,	NULL
P.	NULL
Dubreuil	NULL
,	NULL
R.	NULL
der	NULL
Waal	NULL
Malefijt	NULL
,	NULL
M.	NULL
P'Ebusque	NULL
,	NULL
Y.	NULL
Carcassone	NULL
,	NULL
and	NULL
P.	NULL
Mannoni	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
human	NULL
interleukin	NULL
1	NULL
alpha	NULL
gene	NULL
is	NULL
located	NULL
on	NULL
the	NULL
long	NULL
arm	NULL
of	NULL
chromosome	NULL
2	NULL
at	NULL
g13	NULL
.	NULL

Blood	NULL
73:104-107	NULL
.	NULL

Laimins	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
M.	NULL
Kessel	NULL
,	NULL
R.	NULL
Pozzatti	NULL
,	NULL
and	NULL
G.	NULL
Khoury	NULL
.	NULL

1984	NULL
.	NULL

Characterization	NULL
of	NULL
enhancer	NULL
elements	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
Moloney	NULL
murine	NULL
sarcoma	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

49:183-189	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40.	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Broc	NULL
.	NULL

LeClair	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
M.	NULL
A.	NULL
Blanar	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
p50	NULL
subunit	NULL
of	NULL
NF-kB	NULL
associates	NULL
with	NULL
the	NULL
NF-IL6	NULL
transcription	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:8145-8149	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
K.	NULL
Rustgi	NULL
,	NULL
R.	NULL
Schievella	NULL
,	NULL
and	NULL
R.	NULL
Bernards	NULL
.	NULL

1989	NULL
.	NULL

Suppression	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
gene	NULL
expression	NULL
by	NULL
N-myc	NULL
through	NULL
enhancer	NULL
inactivation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:3351-3355	NULL
.	NULL

Miyamoto	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
Y.	NULL
Kimura	NULL
,	NULL
M.	NULL
Maruyama	NULL
,	NULL
H.	NULL
Harada	NULL
,	NULL
Y.	NULL
Sudo	NULL
,	NULL
T.	NULL
Miyata	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1988	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
nuclear	NULL
factor	NULL
,	NULL
IRF-1	NULL
,	NULL
that	NULL
specifically	NULL
binds	NULL
to	NULL
IFN-B	NULL
gene	NULL
regulatory	NULL
elements	NULL
.	NULL

Cell	NULL
54:903-913	NULL
.	NULL

Natsuka	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
S.	NULL
Hashimoto	NULL
,	NULL
T.	NULL
Sugita	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

Macrophage	NULL
differentiation-specific	NULL
expression	NULL
of	NULL
NF-IL6	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
for	NULL
inter-leukin-6	NULL
.	NULL

Blood	NULL
79:460-466	NULL
.	NULL

Poli	NULL
,	NULL
V.	NULL
,	NULL
F.	NULL
P.	NULL
Mancini	NULL
,	NULL
and	NULL
R.	NULL
Cortese	NULL
.	NULL

1990	NULL
.	NULL

IL-6DBP	NULL
,	NULL
a	NULL
nuclear	NULL
protein	NULL
involved	NULL
in	NULL
interleukin-6	NULL
signal	NULL
transduction	NULL
,	NULL
defines	NULL
a	NULL
new	NULL
family	NULL
of	NULL
leucine	NULL
zipper	NULL
proteins	NULL
related	NULL
to	NULL
C/EBP	NULL
.	NULL

Cell	NULL
63:643-653	NULL
.	NULL

Prywes	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1986	NULL
.	NULL

Inducible	NULL
binding	NULL
of	NULL
a	NULL
factor	NULL
to	NULL
the	NULL
c-fos	NULL
enhancer	NULL
.	NULL

Cell	NULL
47:777-784	NULL
.	NULL

Raschke	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
S.	NULL
Baird	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
I.	NULL
Nakoinz	NULL
.	NULL

1978	NULL
.	NULL

Functional	NULL
macrophage	NULL
cell	NULL
lines	NULL
transformed	NULL
by	NULL
Abelson	NULL
leukemia	NULL
virus	NULL
.	NULL

Cell	NULL
15:261-267	NULL
.	NULL

Rigby	NULL
,	NULL
P.	NULL
W.	NULL
J	NULL
.	NULL

1982	NULL
.	NULL

Expression	NULL
of	NULL
cloned	NULL
genes	NULL
in	NULL
eukaryotic	NULL
cells	NULL
using	NULL
vector	NULL
systems	NULL
derived	NULL
from	NULL
viral	NULL
replicons	NULL
,	NULL
p.	NULL
83-141	NULL
.	NULL

In	NULL
R.	NULL
Williamson	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Genetic	NULL
engineering	NULL
3	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Saito	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Auron	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Schindler	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Ghezzi	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Dinarello	NULL
.	NULL

1990	NULL
.	NULL

IL-1	NULL
induces	NULL
IL-1	NULL
.	NULL

IV	NULL
.	NULL

IFN-y	NULL
suppresses	NULL
IL-1	NULL
but	NULL
not	NULL
lipopolysaccharide-induced	NULL
transcription	NULL
of	NULL
IL-1	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:2216-2222	NULL
.	NULL

Shannon	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
L.	NULL
M.	NULL
Pell	NULL
,	NULL
M.	NULL
J.	NULL
Lenardo	NULL
,	NULL
E.	NULL
S.	NULL
Kuczek	NULL
,	NULL
F.	NULL
S.	NULL
Occhiodoro	NULL
,	NULL
S.	NULL
M.	NULL
Dunn	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Vadas	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
novel	NULL
tumor	NULL
necrosis	NULL
factor-responsive	NULL
transcription	NULL
factor	NULL
in	NULL
hemopoietic	NULL
growth	NULL
factor	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:2950-2959	NULL
.	NULL

Shirakawa	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
S.	NULL
B.	NULL
Mizel	NULL
.	NULL

1989	NULL
.	NULL

In	NULL
vitro	NULL
activation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
catalyzed	NULL
by	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
C.	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:2424-2430	NULL
.	NULL

Sleigh	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
nonchromatographic	NULL
assay	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
in	NULL
eukaryotic	NULL
cells	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

156:251-256	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Auron	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Webb	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
P.	NULL
E.	NULL
Auron	NULL
,	NULL
A	NULL
.	NULL

Rich	NULL
,	NULL
L.	NULL
J.	NULL
Rosenwasser	NULL
,	NULL
S.	NULL
M.	NULL
Wolff	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Dinarello	NULL
.	NULL

1985	NULL
.	NULL

The	NULL
molecular	NULL
cloning	NULL
of	NULL
human	NULL
interleukin-1	NULL
precursor	NULL
cDNA	NULL
and	NULL
its	NULL
expression	NULL
in	NULL
monkey	NULL
cells	NULL
,	NULL
p.	NULL
685-695	NULL
.	NULL

In	NULL
C.	NULL
Sorg	NULL
and	NULL
A.	NULL
Schimpl	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Cellular	NULL
and	NULL
molecular	NULL
biology	NULL
of	NULL
lymphokines	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Webb	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
K.	NULL
L.	NULL
Collins	NULL
,	NULL
P.	NULL
E.	NULL
Auron	NULL
,	NULL
R.	NULL
L.	NULL
Eddy	NULL
,	NULL
H.	NULL
Nakai	NULL
,	NULL
M.	NULL
G.	NULL
Byers	NULL
,	NULL
L.	NULL
L.	NULL
Haley	NULL
,	NULL
M.	NULL
Henry	NULL
,	NULL
and	NULL
T.	NULL
B	NULL
.	NULL

Shows	NULL
.	NULL

1986	NULL
.	NULL

Interleukin-1	NULL
gene	NULL
(	NULL
IL1	NULL
)	NULL
assigned	NULL
to	NULL
long	NULL
arm	NULL
of	NULL
human	NULL
chromosome	NULL
2	NULL
.	NULL

Lymphokine	NULL
Res	NULL
.	NULL

5:77-85	NULL
.	NULL

Williams	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
C.	NULL
A.	NULL
Cantwell	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Johnson	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
family	NULL
of	NULL
C/EBP	NULL
-related	NULL
proteins	NULL
capable	NULL
of	NULL
forming	NULL
covalently	NULL
linked	NULL
leucine	NULL
zipper	NULL
dimers	NULL
in	NULL
vitro	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:1553-1567	NULL
.	NULL

Wingfield	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Payton	NULL
,	NULL
J.	NULL
Tavernier	NULL
,	NULL
M.	NULL
Barnes	NULL
,	NULL
A.	NULL
Shaw	NULL
,	NULL
K.	NULL
Rose	NULL
,	NULL
M.	NULL
G.	NULL
Simona	NULL
,	NULL
S.	NULL
Demczuk	NULL
,	NULL
K.	NULL
Williamson	NULL
,	NULL
and	NULL
J.-M.	NULL
Dayer	NULL
.	NULL

1986	NULL
.	NULL

Purification	NULL
and	NULL
characterization	NULL
of	NULL
human	NULL
inter-leukin-1B	NULL
expressed	NULL
in	NULL
recombinant	NULL
Escherichia	NULL
coli	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

160:491-497	NULL
.	NULL

